[S02DA03, antipyrine, Potassium citrate may increase the hyperkalemic activities of Antipyrine.]
[J01GA01, streptomycin, Potassium citrate may increase the excretion rate of Streptomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[M03AB01, succinylcholine, Potassium citrate may increase the hyperkalemic activities of Succinylcholine.]
[A02BX02, sucralfate, Potassium citrate may increase the excretion rate of Sucralfate which could result in a lower serum level and potentially a reduction in efficacy.]
[J01CG01, sulbactam, Potassium citrate may increase the excretion rate of Sulbactam which could result in a lower serum level and potentially a reduction in efficacy.]
[J01EC02, sulfadiazine, Potassium citrate may increase the excretion rate of Sulfadiazine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01EC01, sulfamethoxazole, Potassium citrate may increase the excretion rate of Sulfamethoxazole which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AB02, sulindac, Potassium citrate may increase the hyperkalemic activities of Sulindac.]
[M01AX04, apazone, Potassium citrate may increase the hyperkalemic activities of Azapropazone.]
[N05CD07, temazepam, Potassium citrate may increase the excretion rate of Temazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[R03CC03, terbutaline, Potassium citrate may increase the excretion rate of Terbutaline which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AE07, dabigatran etexilate, Potassium citrate may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.]
[G03BA03, testosterone, Potassium citrate may increase the excretion rate of Testosterone which could result in a lower serum level and potentially a reduction in efficacy.]
[S03AA02, tetracycline, Potassium citrate may increase the excretion rate of Tetracycline which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Potassium citrate may increase the excretion rate of Thiabendazole which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AD03, thiethylperazine, Potassium citrate may increase the excretion rate of Thiethylperazine which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE06, moxisylyte, Potassium citrate may increase the excretion rate of Moxisylyte which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AL03, tiapride, Potassium citrate may increase the excretion rate of Tiapride which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AC05, ticlopidine, Potassium citrate may increase the excretion rate of Ticlopidine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AX01, tilidine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Tilidine.]
[S01ED01, timolol, Potassium citrate may increase the excretion rate of Timolol which could result in a lower serum level and potentially a reduction in efficacy.]
[P01AB02, tinidazole, Potassium citrate may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AA12, tobramycin, Potassium citrate may increase the excretion rate of Tobramycin which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BB05, tolazamide, Potassium citrate may increase the excretion rate of Tolazamide which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CA01, tolbutamide, Potassium citrate may increase the excretion rate of Tolbutamide which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA21, tolmetin, Potassium citrate may increase the hyperkalemic activities of Tolmetin.]
[N02AX02, tramadol, Potassium citrate may increase the excretion rate of Tramadol which could result in a lower serum level and potentially a reduction in efficacy.]
[C03DB02, triamterene, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Triamterene.]
[N05CD05, triazolam, Potassium citrate may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Potassium citrate may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AD02, trifluridine, Potassium citrate may increase the excretion rate of Trifluridine which could result in a lower serum level and potentially a reduction in efficacy.]
[A03AA05, trimebutine, Potassium citrate may increase the excretion rate of Trimebutine which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AC02, trimethadione, Potassium citrate may increase the hyperkalemic activities of Trimethadione.]
[J01EA01, trimethoprim, Potassium citrate may increase the excretion rate of Trimethoprim which could result in a lower serum level and potentially a reduction in efficacy.]
[C09CA09, azilsartan medoxomil, Potassium citrate may increase the hyperkalemic activities of Azilsartan medoxomil.]
[R03DX07, roflumilast, Potassium citrate may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy.]
[L01FX04, ipilimumab, Potassium citrate may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.]
[R02AA14, oxyquinoline, Potassium citrate may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AA28, vancomycin, Potassium citrate may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AX21, ezogabine, Potassium citrate may increase the excretion rate of Ezogabine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AF01, rivaroxaban, Potassium citrate may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[C08DA01, verapamil, Potassium citrate may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX09, viloxazine, Potassium citrate may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AA03, warfarin, Potassium citrate may increase the excretion rate of Warfarin which could result in a lower serum level and potentially a reduction in efficacy.]
[M05BA05, tiludronic acid, Potassium citrate may increase the excretion rate of Tiludronic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[B06AC02, icatibant, Potassium citrate may increase the excretion rate of Icatibant which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC04, rabeprazole, Potassium citrate may increase the excretion rate of Rabeprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[G03AC10, drospirenone, Potassium citrate may increase the hyperkalemic activities of Drospirenone.]
[V03AC02, deferiprone, Potassium citrate may increase the excretion rate of Deferiprone which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Potassium citrate which could result in a higher serum level.]
[L01EJ01, ruxolitinib, Potassium citrate may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BD07, tolterodine, Potassium citrate may increase the excretion rate of Tolterodine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DH04, doripenem, Potassium citrate may increase the excretion rate of Doripenem which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB03, atenolol, Potassium citrate may increase the hyperkalemic activities of Atenolol.]
[M01CB03, auranofin, Potassium citrate may increase the excretion rate of Auranofin which could result in a lower serum level and potentially a reduction in efficacy.]
[B03XA04, peginesatide, Potassium citrate may increase the excretion rate of Peginesatide which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC07, azacitidine, Potassium citrate may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX01, azathioprine, Potassium citrate may increase the excretion rate of Azathioprine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC05, gemcitabine, Potassium citrate may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DF01, aztreonam, Potassium citrate may increase the excretion rate of Aztreonam which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BX01, baclofen, Potassium citrate may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA11, lorcaserin, Potassium citrate may increase the excretion rate of Lorcaserin which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BD12, mirabegron, Potassium citrate may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy.]
[L02BB04, enzalutamide, Potassium citrate may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AX04, linaclotide, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Linaclotide.]
[D02BA02, octinoxate, Potassium citrate may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BD02, rasagiline, Potassium citrate may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA13, lercanidipine, Potassium citrate may increase the hyperkalemic activities of Lercanidipine.]
[V09IX04, fluorodeoxyglucose F18, Potassium citrate may increase the excretion rate of Fludeoxyglucose (18F) which could result in a lower serum level and potentially a reduction in efficacy.]
[V08CA11, gadofosveset, Potassium citrate may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX08, teduglutide, Potassium citrate may increase the excretion rate of Teduglutide which could result in a lower serum level and potentially a reduction in efficacy.]
[C04AX11, bencyclane, Potassium citrate may increase the hyperkalemic activities of Bencyclane.]
[A10BH04, alogliptin, Potassium citrate may increase the excretion rate of Alogliptin which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX09, glycerol phenylbutyrate, Potassium citrate may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, Potassium citrate may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BA10, benorilate, Potassium citrate may increase the hyperkalemic activities of Benorilate.]
[A10BK02, canagliflozin, Potassium citrate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AX06, tegaserod, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Tegaserod.]
[A10AE05, insulin detemir, The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Potassium citrate.]
[L03AA12, ancestim, Potassium citrate may increase the excretion rate of Ancestim which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AH01, celecoxib, Potassium citrate may increase the hyperkalemic activities of Celecoxib.]
[N04AC01, benztropine, Potassium citrate may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.]
[R02AX03, benzydamine, Potassium citrate may increase the excretion rate of Benzydamine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01EE01, trametinib, Potassium citrate may increase the excretion rate of Trametinib which could result in a lower serum level and potentially a reduction in efficacy.]
[V09AX05, florbetapir F-18, Potassium citrate may increase the excretion rate of Florbetapir (18F) which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX28, levomilnacipran, Potassium citrate may increase the excretion rate of Levomilnacipran which could result in a lower serum level and potentially a reduction in efficacy.]
[C08EA02, bepridil, Potassium citrate may increase the hyperkalemic activities of Bepridil.]
[A10BJ03, lixisenatide, Potassium citrate may increase the excretion rate of Lixisenatide which could result in a lower serum level and potentially a reduction in efficacy.]
[C02KX04, macitentan, Potassium citrate may increase the excretion rate of Macitentan which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX26, vortioxetine, Potassium citrate may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.]
[G03AC08, etonogestrel, Potassium citrate may increase the excretion rate of Etonogestrel which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AP08, sofosbuvir, Potassium citrate may increase the excretion rate of Sofosbuvir which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Potassium citrate may increase the excretion rate of Droxidopa which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB04, acebutolol, Potassium citrate may increase the hyperkalemic activities of Acebutolol.]
[N05CH03, tasimelteon, Potassium citrate may increase the excretion rate of Tasimelteon which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA32, apremilast, Potassium citrate may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy.]
[L02BG02, formestane, Potassium citrate may increase the excretion rate of Formestane which could result in a lower serum level and potentially a reduction in efficacy.]
[S01ED02, betaxolol, Potassium citrate may increase the hyperkalemic activities of Betaxolol.]
[V03AB34, fomepizole, Potassium citrate may increase the excretion rate of Fomepizole which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BK03, empagliflozin, Empagliflozin may increase the diuretic activities of Potassium citrate.]
[V08AA01, diatrizoic acid, Potassium citrate may increase the excretion rate of Diatrizoate which could result in a lower serum level and potentially a reduction in efficacy.]
[V08AA04, iothalamic acid, Potassium citrate may increase the excretion rate of Diatrizoate which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AB04, phenolphthalein, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Phenolphthalein.]
[A06AH03, naloxegol, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Naloxegol.]
[A06AG02, bisacodyl, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Bisacodyl.]
[B01AF03, edoxaban, Potassium citrate may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BE01, acetaminophen, Potassium citrate may increase the excretion rate of Acetaminophen which could result in a lower serum level and potentially a reduction in efficacy.]
[L01DC01, bleomycin, Potassium citrate may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[A07DA06, eluxadoline, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Eluxadoline.]
[A06AD03, magnesium peroxide, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Magnesium peroxide.]
[M02AA25, aceclofenac, Potassium citrate may increase the excretion rate of Aceclofenac which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AB11, acemetacin, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Acemetacin.]
[A10AE06, insulin degludec, The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Potassium citrate.]
[V03AB37, idarucizumab, Potassium citrate may increase the excretion rate of Idarucizumab which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG03, ixazomib, Potassium citrate may increase the excretion rate of Ixazomib which could result in a lower serum level and potentially a reduction in efficacy.]
[M04AB05, lesinurad, Potassium citrate may increase the excretion rate of Lesinurad which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AE16, alminoprofen, Potassium citrate may increase the hyperkalemic activities of Alminoprofen.]
[N03AX23, brivaracetam, Potassium citrate may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA08, bromazepam, Potassium citrate may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[A02AD05, aluminum magnesium silicate, Potassium citrate may increase the excretion rate of Almasilate which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA01, amlodipine, Potassium citrate may increase the hyperkalemic activities of Amlodipine.]
[C03CA02, bumetanide, Potassium citrate may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, Potassium citrate may increase the excretion rate of Levobupivacaine which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AA19, bupranolol, Potassium citrate may increase the hyperkalemic activities of Bupranolol.]
[N07BC01, buprenorphine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Buprenorphine.]
[N05BE01, buspirone, Potassium citrate may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XX27, arsenic trioxide, Potassium citrate may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA03, clofezone, Potassium citrate may increase the excretion rate of Rabeprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AF01, butorphanol, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Butorphanol.]
[A06AX07, plecanatide, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Plecanatide.]
[A07EC04, balsalazide, Potassium citrate may increase the hyperkalemic activities of Balsalazide.]
[A06AH05, naldemedine, Potassium citrate may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy.]
[N07XX16, deutetrabenazine, Potassium citrate may increase the excretion rate of Deutetrabenazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BF02, pregabalin, Potassium citrate may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA07, benazepril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Benazepril.]
[P01CA02, benznidazole, Potassium citrate may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF06, abacavir, Potassium citrate may increase the excretion rate of Abacavir which could result in a lower serum level and potentially a reduction in efficacy.]
[N07XX13, valbenazine, Potassium citrate may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01MA23, delafloxacin, Potassium citrate may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC06, capecitabine, Potassium citrate may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB07, bisoprolol, Potassium citrate may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AA17, bopindolol, Potassium citrate may increase the hyperkalemic activities of Bopindolol.]
[C03DA03, canrenone, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Canrenone.]
[R03BA02, budesonide, Potassium citrate may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AB07, bumadizone, Potassium citrate may increase the hyperkalemic activities of Bumadizone.]
[R06AX18, acrivastine, Potassium citrate may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA01, captopril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Captopril.]
[L02BB05, apalutamide, Potassium citrate may increase the excretion rate of Apalutamide which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AF01, carbamazepine, Potassium citrate may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AC08, calcium polycarbophil, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Calcium polycarbophil.]
[C07AG02, carvedilol, Potassium citrate may increase the hyperkalemic activities of Carvedilol.]
[L04AA37, baricitinib, Potassium citrate may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD14, ceftibuten, Potassium citrate may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.]
[J01GB14, plazomicin, Potassium citrate may increase the excretion rate of Plazomicin which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB08, celiprolol, Potassium citrate may increase the hyperkalemic activities of Celiprolol.]
[A16AX14, migalastat, Potassium citrate may increase the excretion rate of Migalastat which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AX17, stiripentol, Potassium citrate may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[J01AA13, eravacycline, The therapeutic efficacy of Eravacycline can be decreased when used in combination with Potassium citrate.]
[J01AA14, sarecycline, The therapeutic efficacy of Sarecycline can be decreased when used in combination with Potassium citrate.]
[J01AA15, omadacycline, The therapeutic efficacy of Omadacycline can be decreased when used in combination with Potassium citrate.]
[S01GX12, cetirizine, Potassium citrate may increase the excretion rate of Cetirizine which could result in a lower serum level and potentially a reduction in efficacy.]
[D08AE05, chloroxylenol, Potassium citrate may increase the excretion rate of Chloroxylenol which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AC05, lornoxicam, Potassium citrate may increase the hyperkalemic activities of Lornoxicam.]
[L01AD01, carmustine, Potassium citrate may increase the excretion rate of Carmustine which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AX05, prucalopride, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Prucalopride.]
[C09AA08, cilazapril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Cilazapril.]
[B01AC23, cilostazol, Potassium citrate may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BA14, solriamfetol, Potassium citrate may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA09, clobazam, Potassium citrate may increase the excretion rate of Clobazam which could result in a lower serum level and potentially a reduction in efficacy.]
[J01AA11, clomocycline, The therapeutic efficacy of Clomocycline can be decreased when used in combination with Potassium citrate.]
[A06AB05, castor oil, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Castor oil.]
[C09CA06, candesartan, Potassium citrate may increase the hyperkalemic activities of Candesartan.]
[J01DC04, cefaclor, Potassium citrate may increase the excretion rate of Cefaclor which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DB05, cefadroxil, Potassium citrate may increase the excretion rate of Cefadroxil which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DC05, cefotetan, Potassium citrate may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD02, ceftazidime, Potassium citrate may increase the excretion rate of Ceftazidime which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD04, ceftriaxone, Potassium citrate may increase the excretion rate of Ceftriaxone which could result in a lower serum level and potentially a reduction in efficacy.]
[N07XX11, pitolisant, Potassium citrate may increase the excretion rate of Pitolisant which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE03, insulin, regular, pork, The therapeutic efficacy of Insulin pork can be decreased when used in combination with Potassium citrate.]
[A06AB03, danthron, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Dantron.]
[J01XX09, daptomycin, Potassium citrate may increase the excretion rate of Daptomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DB01, cephalexin, Potassium citrate may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DB09, cephradine, Potassium citrate may increase the excretion rate of Cefradine which could result in a lower serum level and potentially a reduction in efficacy.]
[M09AX08, golodirsen, Potassium citrate may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AX03, dezocine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Dezocine.]
[R02AA03, dichlorobenzyl alcohol, Potassium citrate may increase the excretion rate of Dichlorobenzyl alcohol which could result in a lower serum level and potentially a reduction in efficacy.]
[G03DB08, dienogest, Potassium citrate may increase the excretion rate of Dienogest which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AA08, dihydrocodeine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Dihydrocodeine.]
[M01AH02, rofecoxib, Potassium citrate may increase the hyperkalemic activities of Rofecoxib.]
[C08CA16, clevidipine, Potassium citrate may increase the excretion rate of Clevidipine which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AC04, droxicam, Potassium citrate may increase the hyperkalemic activities of Droxicam.]
[V08CA05, mangafodipir, Potassium citrate may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA27, dexketoprofen, Potassium citrate may increase the excretion rate of Dexketoprofen which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AX07, oliceridine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Oliceridine.]
[P01BA01, chloroquine, Potassium citrate may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AA01, chlorpromazine, Potassium citrate may increase the excretion rate of Chlorpromazine which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BB02, chlorpropamide, Potassium citrate may increase the excretion rate of Chlorpropamide which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Potassium citrate may increase the excretion rate of Chlorzoxazone which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BA07, ethenzamide, Potassium citrate may increase the hyperkalemic activities of Ethenzamide.]
[N02BA03, choline salicylate, Potassium citrate may increase the excretion rate of Choline salicylate which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BX18, vinpocetine, Potassium citrate may increase the hyperkalemic activities of Vinpocetine.]
[M01AB08, etodolac, Potassium citrate may increase the excretion rate of Etodolac which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA06, etofenamate, Potassium citrate may increase the hyperkalemic activities of Etofenamate.]
[M01AX25, chondroitin sulfates, Potassium citrate may increase the excretion rate of Chondroitin sulfate which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AE05, fenbufen, Potassium citrate may increase the hyperkalemic activities of Fenbufen.]
[C01CA19, fenoldopam, Potassium citrate may increase the excretion rate of Fenoldopam which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD15, cefdinir, Potassium citrate may increase the excretion rate of Cefdinir which could result in a lower serum level and potentially a reduction in efficacy.]
[S02BA08, fluocinolone acetonide, Potassium citrate may increase the excretion rate of Fluocinolone acetonide which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BG07, flupirtine, Potassium citrate may increase the excretion rate of Flupirtine which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AF01, insulin, regular, human, The therapeutic efficacy of Insulin human can be decreased when used in combination with Potassium citrate.]
[A02BA01, cimetidine, Potassium citrate may increase the excretion rate of Cimetidine which could result in a lower serum level and potentially a reduction in efficacy.]
[V08CA04, gadoteridol, Potassium citrate may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.]
[N07CA02, cinnarizine, Potassium citrate may increase the hyperkalemic activities of Cinnarizine.]
[S03AA07, ciprofloxacin, Potassium citrate may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XA01, cisplatin, Potassium citrate may increase the excretion rate of Cisplatin which could result in a lower serum level and potentially a reduction in efficacy.]
[C03DA05, finerenone, Potassium citrate may increase the hyperkalemic activities of Finerenone.]
[V09AB03, ioflupane I-123, Potassium citrate may increase the excretion rate of Ioflupane I-123 which could result in a lower serum level and potentially a reduction in efficacy.]
[V09AA01, technetium Tc 99m exametazime, Potassium citrate may increase the excretion rate of Technetium Tc-99m exametazime which could result in a lower serum level and potentially a reduction in efficacy.]
[V09AX06, florbetaben f-18, Potassium citrate may increase the excretion rate of Florbetaben (18F) which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AG01, mefenamic acid, Potassium citrate may increase the hyperkalemic activities of Mefenamic acid.]
[N01BB10, levobupivacaine, Potassium citrate may increase the excretion rate of Levobupivacaine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA04, clomipramine, Potassium citrate may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AE01, clonazepam, Potassium citrate may increase the excretion rate of Clonazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AH02, oseltamivir, Potassium citrate may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH02, clozapine, Potassium citrate may increase the excretion rate of Clozapine which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AX13, proquazone, Potassium citrate may increase the hyperkalemic activities of Proquazone.]
[R05DA04, codeine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Codeine.]
[M04AC01, colchicine, Potassium citrate may increase the excretion rate of Colchicine which could result in a lower serum level and potentially a reduction in efficacy.]
[A04AA03, tropisetron, Potassium citrate may increase the excretion rate of Tropisetron which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BX03, nateglinide, Potassium citrate may increase the excretion rate of Nateglinide which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BA16, imidazole-2-hydroxybenzoate, Potassium citrate may increase the hyperkalemic activities of Imidazole salicylate.]
[A10AE04, insulin glargine, The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Potassium citrate.]
[B01AC10, indobufen, Potassium citrate may increase the hyperkalemic activities of Indobufen.]
[J05AB14, valganciclovir, Potassium citrate may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C05BB03, invert sugar, Potassium citrate may increase the excretion rate of Invert sugar which could result in a lower serum level and potentially a reduction in efficacy.]
[V08AB09, iodixanol, Potassium citrate may increase the excretion rate of Iodixanol which could result in a lower serum level and potentially a reduction in efficacy.]
[V08AB05, iopromide, Potassium citrate may increase the excretion rate of Iopromide which could result in a lower serum level and potentially a reduction in efficacy.]
[V08AB07, ioversol, Potassium citrate may increase the excretion rate of Ioversol which could result in a lower serum level and potentially a reduction in efficacy.]
[V08AB12, ioxilan, Potassium citrate may increase the excretion rate of Ioxilan which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AH03, valdecoxib, Potassium citrate may increase the hyperkalemic activities of Valdecoxib.]
[N02CC05, almotriptan, Potassium citrate may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AH04, parecoxib, Potassium citrate may increase the hyperkalemic activities of Parecoxib.]
[J02AC02, itraconazole, Potassium citrate may increase the hyperkalemic activities of Itraconazole.]
[B01AB12, bemiparin, Potassium citrate may increase the hyperkalemic activities of Bemiparin.]
[S01AD03, acyclovir, Potassium citrate may increase the excretion rate of Acyclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA10, ketazolam, Potassium citrate may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AA06, kebuzone, Potassium citrate may increase the hyperkalemic activities of Kebuzone.]
[C08CA09, lacidipine, Potassium citrate may increase the hyperkalemic activities of Lacidipine.]
[A06AD12, lactitol, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Lactitol.]
[N03AX09, lamotrigine, Potassium citrate may increase the excretion rate of Lamotrigine which could result in a lower serum level and potentially a reduction in efficacy.]
[N07BC04, lofexidine, Potassium citrate may increase the excretion rate of Lofexidine which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AB09, lonazolac, Potassium citrate may increase the hyperkalemic activities of Lonazolac.]
[M02AA31, loxoprofen, Potassium citrate may increase the hyperkalemic activities of Loxoprofen.]
[C09AA03, lisinopril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Lisinopril.]
[A06AD01, magnesium carbonate, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Magnesium carbonate.]
[C08CA11, manidipine, Potassium citrate may increase the hyperkalemic activities of Manidipine.]
[C07AA14, mepindolol, Potassium citrate may increase the hyperkalemic activities of Mepindolol.]
[J01DH02, meropenem, Potassium citrate may increase the excretion rate of Meropenem which could result in a lower serum level and potentially a reduction in efficacy.]
[C04AX01, cyclandelate, Potassium citrate may increase the hyperkalemic activities of Cyclandelate.]
[R03CB02, methoxyphenamine, The excretion of Methoxyphenamine can be decreased when combined with Potassium citrate.]
[C03DA04, eplerenone, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Eplerenone.]
[N05AD03, metylperon, Potassium citrate may increase the excretion rate of Melperone which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, Potassium citrate may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[S01XA18, cyclosporine, Potassium citrate may increase the hyperkalemic activities of Cyclosporine.]
[C09AA13, moexipril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Moexipril.]
[M02AA02, mofebutazone, Potassium citrate may increase the hyperkalemic activities of Mofebutazone.]
[M01AX22, morniflumate, Potassium citrate may increase the hyperkalemic activities of Morniflumate.]
[M01AH05, etoricoxib, Potassium citrate may increase the hyperkalemic activities of Etoricoxib.]
[L01AX04, dacarbazine, Potassium citrate may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[M03CA01, dantrolene, Potassium citrate may increase the hyperkalemic activities of Dantrolene.]
[M01AX01, nabumetone, Potassium citrate may increase the hyperkalemic activities of Nabumetone.]
[N07BB05, nalmefene, Potassium citrate may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA15, potassium lactate, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Potassium lactate.]
[J01AA01, demeclocycline, The therapeutic efficacy of Demeclocycline can be decreased when used in combination with Potassium citrate.]
[C07AB12, nebivolol, Potassium citrate may increase the hyperkalemic activities of Nebivolol.]
[S01GX04, nedocromil, Potassium citrate may increase the excretion rate of Nedocromil which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX06, nefazodone, Potassium citrate may increase the excretion rate of Nefazodone which could result in a lower serum level and potentially a reduction in efficacy.]
[C01DX16, nicorandil, Potassium citrate may increase the excretion rate of Nicorandil which could result in a lower serum level and potentially a reduction in efficacy.]
[L02BB02, nilutamide, Potassium citrate may increase the excretion rate of Nilutamide which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA23, theodrenaline, The risk or severity of Cardiac Arrhythmia can be increased when Theodrenaline is combined with Potassium citrate.]
[R05DA06, normethadone, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Normethadone.]
[B01AX05, fondaparinux, Potassium citrate may increase the excretion rate of Fondaparinux which could result in a lower serum level and potentially a reduction in efficacy.]
[A07EC03, olsalazine, Potassium citrate may increase the hyperkalemic activities of Olsalazine.]
[N06AA01, desipramine, Potassium citrate may increase the excretion rate of Desipramine which could result in a lower serum level and potentially a reduction in efficacy.]
[H01BA02, desmopressin, Potassium citrate may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CH02, indigo carmine, Potassium citrate may increase the excretion rate of Indigotindisulfonic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DH03, ertapenem, Potassium citrate may increase the excretion rate of Ertapenem which could result in a lower serum level and potentially a reduction in efficacy.]
[C09XA02, aliskiren, Potassium citrate may increase the hyperkalemic activities of Aliskiren.]
[M01AE12, oxaprozin, Potassium citrate may increase the excretion rate of Oxaprozin which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BA02, dextroamphetamine, The excretion of Amphetamine can be decreased when combined with Potassium citrate.]
[N02AC01, dextromoramide, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Dextromoramide.]
[N07BC06, heroin, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Diamorphine.]
[C01DA05, pentaerythritol tetranitrate, Potassium citrate may increase the excretion rate of Pentaerythritol tetranitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[P03AC04, permethrin, Potassium citrate may increase the excretion rate of Permethrin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA01, diazepam, Potassium citrate may increase the excretion rate of Diazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[R05DA08, pholcodine, Potassium citrate may increase the excretion rate of Pholcodine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Potassium citrate may increase the hyperkalemic activities of Diclofenac.]
[A03AA07, dicyclomine, Potassium citrate may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF02, didanosine, Potassium citrate may increase the excretion rate of Didanosine which could result in a lower serum level and potentially a reduction in efficacy.]
[A03AX04, pinaverium, Potassium citrate may increase the hyperkalemic activities of Pinaverium.]
[A08AA03, diethylpropion, The excretion of Diethylpropion can be decreased when combined with Potassium citrate.]
[C08CA03, isradipine, Potassium citrate may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy.]
[D07XC04, diflucortolone, Potassium citrate may increase the excretion rate of Difluocortolone which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BA11, diflunisal, Potassium citrate may increase the excretion rate of Diflunisal which could result in a lower serum level and potentially a reduction in efficacy.]
[C01AA05, digoxin, Potassium citrate may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AA03, hydromorphone, Potassium citrate may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX04, lenalidomide, Potassium citrate may increase the excretion rate of Lenalidomide which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BC01, potassium perchlorate, Potassium citrate may increase the excretion rate of Potassium perchlorate which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB04, pralidoxime, Potassium citrate may increase the excretion rate of Pralidoxime which could result in a lower serum level and potentially a reduction in efficacy.]
[C08DB01, diltiazem, Potassium citrate may increase the hyperkalemic activities of Diltiazem.]
[V03AB09, dimercaprol, Potassium citrate may increase the excretion rate of Dimercaprol which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AX03, dimethyl sulfoxide, Potassium citrate may increase the excretion rate of Dimethyl sulfoxide which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BB04, propyphenazone, Potassium citrate may increase the hyperkalemic activities of Propyphenazone.]
[M01AB14, proglumetacin, Potassium citrate may increase the hyperkalemic activities of Proglumetacin.]
[A07DA01, diphenoxylate, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Diphenoxylate.]
[C09AA06, quinapril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Quinapril.]
[C09AA05, ramipril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Ramipril.]
[S01AX06, resorcinol, Potassium citrate may increase the excretion rate of Resorcinol which could result in a lower serum level and potentially a reduction in efficacy.]
[C01BA03, disopyramide, Potassium citrate may increase the excretion rate of Disopyramide which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AE09, levocetirizine, Potassium citrate may increase the excretion rate of Levocetirizine which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB09, ropivacaine, Potassium citrate may increase the excretion rate of Ropivacaine which could result in a lower serum level and potentially a reduction in efficacy.]
[C03XA01, tolvaptan, Potassium citrate may increase the hyperkalemic activities of Tolvaptan.]
[G04BE08, tadalafil, Potassium citrate may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC05, ketorolac, Potassium citrate may increase the hyperkalemic activities of Ketorolac.]
[C01EB18, ranolazine, Potassium citrate may increase the excretion rate of Ranolazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BA06, salsalate, Potassium citrate may increase the hyperkalemic activities of Salsalate.]
[H05BA01, salmon calcitonin, Potassium citrate may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA07, dobutamine, Potassium citrate may increase the excretion rate of Dobutamine which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA04, dopamine, Potassium citrate may increase the excretion rate of Dopamine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA12, doxepin, Potassium citrate may increase the excretion rate of Doxepin which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AB06, sennosides, USP, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Sennosides.]
[J01AA02, doxycycline, Potassium citrate may increase the excretion rate of Doxycycline which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA10, sibutramine, Potassium citrate may increase the excretion rate of Sibutramine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AG05, sodium phosphate, Potassium citrate may increase the nephrotoxic activities of Sodium phosphate, monobasic.]
[A12CA02, sodium sulfate, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Sodium sulfate.]
[C09AA11, spirapril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Spirapril.]
[R03DA01, dyphylline, Potassium citrate may increase the excretion rate of Dyphylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CC01, sumatriptan, Potassium citrate may increase the excretion rate of Sumatriptan which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CX07, edrophonium, Potassium citrate may increase the excretion rate of Edrophonium which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB13, talinolol, Potassium citrate may increase the hyperkalemic activities of Talinolol.]
[L01AX03, temozolomide, Potassium citrate may increase the excretion rate of Temozolomide which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AC02, tenoxicam, Potassium citrate may increase the hyperkalemic activities of Tenoxicam.]
[G04BD05, terodiline, Potassium citrate may increase the hyperkalemic activities of Terodiline.]
[C07AA16, tertatolol, Potassium citrate may increase the hyperkalemic activities of Tertatolol.]
[C09AA02, enalapril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Enalapril.]
[M01AG02, tolfenamic acid, Potassium citrate may increase the hyperkalemic activities of Tolfenamic acid.]
[N06AG03, toloxatone, Potassium citrate may increase the excretion rate of Toloxatone which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BA09, atomoxetine, Potassium citrate may increase the excretion rate of Atomoxetine which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AX11, topiramate, Potassium citrate may increase the excretion rate of Topiramate which could result in a lower serum level and potentially a reduction in efficacy.]
[J01AA12, tigecycline, The therapeutic efficacy of Tigecycline can be decreased when used in combination with Potassium citrate.]
[C09AA10, trandolapril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Trandolapril.]
[N05CC01, chloral hydrate, Potassium citrate may increase the excretion rate of Chloral hydrate which could result in a lower serum level and potentially a reduction in efficacy.]
[S01FB02, ephedrine, The risk or severity of Cardiac Arrhythmia can be increased when Ephedrine is combined with Potassium citrate.]
[N06AX16, venlafaxine, Potassium citrate may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA12, mepirodipine, Potassium citrate may increase the hyperkalemic activities of Barnidipine.]
[S01EA01, epinephrine, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Potassium citrate.]
[C09AA15, zofenopril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Zofenopril.]
[M01AB04, zomepirac, Potassium citrate may increase the hyperkalemic activities of Zomepirac.]
[N03AX15, zonisamide, Potassium citrate may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AB06, insulin glulisine, human, The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Potassium citrate.]
[L01XA02, carboplatin, Potassium citrate may increase the excretion rate of Carboplatin which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AC02, guanfacine, Potassium citrate may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AX05, pidotimod, Potassium citrate may increase the excretion rate of Pidotimod which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD04, estazolam, Potassium citrate may increase the excretion rate of Estazolam which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC02, pantoprazole, Potassium citrate may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA03, estradiol, Potassium citrate may increase the excretion rate of Estradiol which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Potassium citrate may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[J04AK02, ethambutol, Potassium citrate may increase the excretion rate of Ethambutol which could result in a lower serum level and potentially a reduction in efficacy.]
[V08CA03, gadodiamide, Potassium citrate may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA15, gepefrine, The excretion of Gepefrine can be decreased when combined with Potassium citrate.]
[C01BD05, ibutilide, Potassium citrate may increase the excretion rate of Ibutilide which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AD01, ethosuximide, Potassium citrate may increase the hyperkalemic activities of Ethosuximide.]
[M01AC06, meloxicam, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Meloxicam.]
[S01XA06, ethylmorphine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Ethylmorphine.]
[N01AX07, etomidate, Potassium citrate may increase the excretion rate of Etomidate which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AD02, tacrolimus, Potassium citrate may increase the hyperkalemic activities of Tacrolimus.]
[P01AX07, trimetrexate, Potassium citrate may increase the excretion rate of Trimetrexate which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX12, bupropion, Potassium citrate may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AB08, fluvoxamine, Potassium citrate may increase the excretion rate of Fluvoxamine which could result in a lower serum level and potentially a reduction in efficacy.]
[L02AE02, leuprolide, Potassium citrate may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.]
[M01CB01, gold sodium thiomalate, Potassium citrate may increase the excretion rate of Sodium aurothiomalate which could result in a lower serum level and potentially a reduction in efficacy.]
[B05AA05, dextran, Potassium citrate may increase the excretion rate of Dextran which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AF02, dexrazoxane, Potassium citrate may increase the excretion rate of Dexrazoxane which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AA01, levocarnitine, Potassium citrate may increase the excretion rate of Levocarnitine which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA02, felodipine, Potassium citrate may increase the hyperkalemic activities of Felodipine.]
[C08EA01, fendiline, Potassium citrate may increase the hyperkalemic activities of Fendiline.]
[M01AE04, fenoprofen, Potassium citrate may increase the hyperkalemic activities of Fenoprofen.]
[N02AB03, fentanyl, Potassium citrate may increase the excretion rate of Fentanyl which could result in a lower serum level and potentially a reduction in efficacy.]
[R03CC02, albuterol, Potassium citrate may increase the excretion rate of Salbutamol which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BB06, clofarabine, Potassium citrate may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[N07AX03, cevimeline, Potassium citrate may increase the excretion rate of Cevimeline which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BD02, flavoxate, Potassium citrate may increase the excretion rate of Flavoxate which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BG04, floctafenine, Potassium citrate may increase the hyperkalemic activities of Floctafenine.]
[J02AC01, fluconazole, Potassium citrate may increase the excretion rate of Fluconazole which could result in a lower serum level and potentially a reduction in efficacy.]
[J02AX01, flucytosine, Potassium citrate may increase the excretion rate of Flucytosine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB25, flumazenil, Potassium citrate may increase the excretion rate of Flumazenil which could result in a lower serum level and potentially a reduction in efficacy.]
[N07CA03, flunarizine, Potassium citrate may increase the hyperkalemic activities of Flunarizine.]
[L01BC09, floxuridine, Potassium citrate may increase the excretion rate of Floxuridine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD01, flurazepam, Potassium citrate may increase the excretion rate of Flurazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC04, flurbiprofen, Potassium citrate may increase the excretion rate of Flurbiprofen which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AG01, fluspirilene, Potassium citrate may increase the hyperkalemic activities of Fluspirilene.]
[L02BB01, flutamide, Potassium citrate may increase the excretion rate of Flutamide which could result in a lower serum level and potentially a reduction in efficacy.]
[S02AA17, fosfomycin, Potassium citrate may increase the excretion rate of Fosfomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC03, tegafur, Potassium citrate may increase the excretion rate of Tegafur which could result in a lower serum level and potentially a reduction in efficacy.]
[C03CA01, furosemide, Potassium citrate may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, Potassium citrate may increase the excretion rate of Eszopiclone which could result in a lower serum level and potentially a reduction in efficacy.]
[C08DA02, gallopamil, Potassium citrate may increase the hyperkalemic activities of Gallopamil.]
[S01AD09, ganciclovir, Potassium citrate may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C10AB04, gemfibrozil, Potassium citrate may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XA03, telavancin, Potassium citrate may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AD03, methsuximide, Potassium citrate may increase the hyperkalemic activities of Methsuximide.]
[N01AH02, alfentanil, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Alfentanil.]
[A10BB07, glipizide, Potassium citrate may increase the excretion rate of Glipizide which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CM18, dexmedetomidine, Potassium citrate may increase the excretion rate of Dexmedetomidine which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AX01, glycerin, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Glycerin.]
[L01EX02, sorafenib, Potassium citrate may increase the excretion rate of Sorafenib which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB09, esmolol, Potassium citrate may increase the hyperkalemic activities of Esmolol.]
[M01CB04, aurothioglucose, Potassium citrate may increase the excretion rate of Aurothioglucose which could result in a lower serum level and potentially a reduction in efficacy.]
[S01LA03, pegaptanib, Potassium citrate may increase the excretion rate of Pegaptanib which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA09, fosinopril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Fosinopril.]
[S01EX01, guanethidine, Potassium citrate may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.]
[L02AE03, goserelin, Potassium citrate may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD01, haloperidol, Potassium citrate may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH04, quetiapine, Potassium citrate may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BX13, idebenone, Potassium citrate may increase the excretion rate of Idebenone which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AD05, insulin aspart, human, The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Potassium citrate.]
[M04AA01, allopurinol, Potassium citrate may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[C09CA01, losartan, Potassium citrate may increase the hyperkalemic activities of Losartan.]
[S01XA14, heparin, Potassium citrate may increase the hyperkalemic activities of Heparin.]
[G03DC01, allylestrenol, Potassium citrate may increase the excretion rate of Allylestrenol which could result in a lower serum level and potentially a reduction in efficacy.]
[A07EC02, mesalamine, Potassium citrate may increase the hyperkalemic activities of Mesalazine.]
[C01CE02, milrinone, Potassium citrate may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.]
[A12CD02, sodium monofluorophosphate, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Sodium fluorophosphate.]
[C08CA10, nilvadipine, Potassium citrate may increase the hyperkalemic activities of Nilvadipine.]
[M02AA26, nimesulide, Potassium citrate may increase the hyperkalemic activities of Nimesulide.]
[C09AA04, perindopril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Perindopril.]
[C02DB02, hydralazine, Potassium citrate may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[R05DA03, hydrocodone, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Hydrocodone.]
[B05XA17, potassium acetate, Potassium citrate may increase the excretion rate of Potassium acetate which could result in a lower serum level and potentially a reduction in efficacy.]
[S01XA07, aluminum potassium sulfate, Potassium alum may increase the hyperkalemic activities of Potassium citrate.]
[V03AB33, hydroxocobalamin, Potassium citrate may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BD06, propiverine, Potassium citrate may increase the excretion rate of Propiverine which could result in a lower serum level and potentially a reduction in efficacy.]
[B05AA07, hetastarch, Potassium citrate may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.]
[R02AX02, ibuprofen, Potassium citrate may increase the excretion rate of Ibuprofen which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA08, sodium acetate, Potassium citrate may increase the excretion rate of Sodium acetate which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AD21, sodium tartrate, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Sodium tartrate.]
[L01AA06, ifosfamide, Potassium citrate may increase the excretion rate of Ifosfamide which could result in a lower serum level and potentially a reduction in efficacy.]
[N01AH03, sufentanil, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Sufentanil.]
[N06AA02, imipramine, Potassium citrate may increase the excretion rate of Imipramine which could result in a lower serum level and potentially a reduction in efficacy.]
[R01AD07, tixocortol, Potassium citrate may increase the excretion rate of Tixocortol which could result in a lower serum level and potentially a reduction in efficacy.]
[L01CE01, topotecan, Potassium citrate may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.]
[C03BA11, indapamide, Potassium citrate may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Potassium citrate may increase the hyperkalemic activities of Indomethacin.]
[N06AX17, milnacipran, Potassium citrate may increase the excretion rate of Milnacipran which could result in a lower serum level and potentially a reduction in efficacy.]
[S01XA28, varenicline, Potassium citrate may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BH01, sitagliptin, Potassium citrate may increase the excretion rate of Sitagliptin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA12, alprazolam, Potassium citrate may increase the excretion rate of Alprazolam which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CH02, ramelteon, Potassium citrate may increase the excretion rate of Ramelteon which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AA01, alprenolol, Potassium citrate may increase the hyperkalemic activities of Alprenolol.]
[V03AB01, ipecac, Potassium citrate may increase the excretion rate of Ipecac which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA16, imidapril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Imidapril.]
[J04AC01, isoniazid, Potassium citrate may increase the excretion rate of Isoniazid which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AX05, inosine pranobex, Potassium citrate may increase the excretion rate of Inosine pranobex which could result in a lower serum level and potentially a reduction in efficacy.]
[C01DA14, isosorbide mononitrate, Potassium citrate may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[D10BA01, isotretinoin, Potassium citrate may increase the excretion rate of Isotretinoin which could result in a lower serum level and potentially a reduction in efficacy.]
[A02AB01, aluminum hydroxide, Potassium citrate can cause an increase in the absorption of Aluminum hydroxide resulting in an increased serum concentration and potentially a worsening of adverse effects.]
[N01AX03, ketamine, Potassium citrate may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AC22, prasugrel, Potassium citrate may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.]
[J02AB02, ketoconazole, Potassium citrate may increase the hyperkalemic activities of Ketoconazole.]
[M02AA10, ketoprofen, Potassium citrate may increase the excretion rate of Ketoprofen which could result in a lower serum level and potentially a reduction in efficacy.]
[D10AX03, azelaic acid, Potassium citrate may increase the excretion rate of Azelaic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AE11, tiaprofenic acid, Potassium citrate may increase the hyperkalemic activities of Tiaprofenic acid.]
[C07AG01, labetalol, Potassium citrate may increase the excretion rate of Labetalol which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BB01, amantadine, Potassium citrate may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AD11, lactulose, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Lactulose.]
[A06AX03, lubiprostone, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Lubiprostone.]
[C08EX01, lidoflazine, Potassium citrate may increase the hyperkalemic activities of Lidoflazine.]
[C03DB01, amiloride, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Amiloride.]
[A07DA03, loperamide, Potassium citrate may increase the hyperkalemic activities of Loperamide.]
[N05BA06, lorazepam, Potassium citrate may increase the excretion rate of Lorazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[J01AA04, lymecycline, The therapeutic efficacy of Lymecycline can be decreased when used in combination with Potassium citrate.]
[B05XA11, magnesium chloride, Potassium citrate may increase the excretion rate of Magnesium chloride which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BX01, magnesium hydroxide, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Magnesium hydroxide.]
[V04CC02, magnesium sulfate, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Magnesium sulfate.]
[L01BA05, pralatrexate, Potassium citrate may increase the excretion rate of Pralatrexate which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CX04, mannitol, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Mannitol.]
[N06AA21, maprotiline, Potassium citrate may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy.]
[C02BB01, mecamylamine, Potassium citrate may increase the excretion rate of Mecamylamine which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA18, meclofenamic acid, Potassium citrate may increase the excretion rate of Meclofenamic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AB07, cascara sagrada, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Frangula purshiana bark.]
[B01AB06, nadroparin, Potassium citrate may increase the hyperkalemic activities of Nadroparin.]
[B01AB05, enoxaparin, Potassium citrate may increase the hyperkalemic activities of Enoxaparin.]
[B01AB04, dalteparin, Potassium citrate may increase the hyperkalemic activities of Dalteparin.]
[N06DX01, memantine, The excretion of Memantine can be decreased when combined with Potassium citrate.]
[N02AB02, meperidine, Potassium citrate may increase the excretion rate of Meperidine which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA11, mephentermine, The excretion of Mephentermine can be decreased when combined with Potassium citrate.]
[N01BB03, mepivacaine, Potassium citrate may increase the excretion rate of Mepivacaine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AX05, meptazinol, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Meptazinol.]
[G04BX16, tiopronin, Potassium citrate may increase the excretion rate of Tiopronin which could result in a lower serum level and potentially a reduction in efficacy.]
[C03BC01, mersalyl, Potassium citrate may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Potassium citrate may increase the excretion rate of Paliperidone which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BA02, metformin, Potassium citrate may increase the excretion rate of Metformin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01AA05, methacycline, The therapeutic efficacy of Metacycline can be decreased when used in combination with Potassium citrate.]
[N07BC02, methadone, Potassium citrate may increase the excretion rate of Methadone which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BA03, methamphetamine, The excretion of Metamfetamine can be decreased when combined with Potassium citrate.]
[J05AF05, lamivudine, Potassium citrate may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, Potassium citrate may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BA04, pemetrexed, Potassium citrate may increase the excretion rate of Pemetrexed which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BG08, ziconotide, The risk or severity of CNS depression can be increased when Potassium citrate is combined with Ziconotide.]
[L04AX03, methotrexate, Potassium citrate may increase the excretion rate of Methotrexate which could result in a lower serum level and potentially a reduction in efficacy.]
[D05BA02, methoxsalen, Potassium citrate may increase the excretion rate of Methoxsalen which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AC06, methylcellulose, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Methylcellulose.]
[C02AB01, methyldopa, Potassium citrate may increase the excretion rate of Methyldopa which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CG05, methylene blue, Potassium citrate may increase the excretion rate of Methylene blue which could result in a lower serum level and potentially a reduction in efficacy.]
[G03EK01, methyltestosterone, Potassium citrate may increase the excretion rate of Methyltestosterone which could result in a lower serum level and potentially a reduction in efficacy.]
[C03BA08, metolazone, Potassium citrate may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Potassium citrate may increase the excretion rate of Metoprolol which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CD01, metyrapone, Potassium citrate may increase the excretion rate of Metyrapone which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BB03, aminopyrine, Potassium citrate may increase the hyperkalemic activities of Aminophenazone.]
[B01AB07, parnaparin, Potassium citrate may increase the hyperkalemic activities of Parnaparin.]
[N05CD08, midazolam, Potassium citrate may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB10, tinzaparin, Potassium citrate may increase the hyperkalemic activities of Tinzaparin.]
[A06AA01, mineral oil, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Mineral oil.]
[J05AH01, zanamivir, Potassium citrate may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.]
[C09CA03, valsartan, Potassium citrate may increase the hyperkalemic activities of Valsartan.]
[J01AA08, minocycline, The therapeutic efficacy of Minocycline can be decreased when used in combination with Potassium citrate.]
[N06BA12, lisdexamfetamine, The excretion of Lisdexamfetamine can be decreased when combined with Potassium citrate.]
[L03AC01, aldesleukin, Potassium citrate may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.]
[C01BD01, amiodarone, Potassium citrate may increase the hyperkalemic activities of Amiodarone.]
[N06AA09, amitriptyline, Potassium citrate may increase the excretion rate of Amitriptyline which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AA01, morphine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Morphine.]
[A04AA05, palonosetron, Potassium citrate may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AB05, certolizumab pegol, Potassium citrate may increase the excretion rate of Certolizumab pegol which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BA01, ammonium chloride, Potassium citrate may increase the excretion rate of Ammonium chloride which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA06, mycophenolic acid, Potassium citrate may increase the excretion rate of Mycophenolic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AA12, nadolol, Potassium citrate may increase the excretion rate of Nadolol which could result in a lower serum level and potentially a reduction in efficacy.]
[J01CA04, amoxicillin, Potassium citrate may increase the excretion rate of Amoxicillin which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AF02, nalbuphine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Nalbuphine.]
[V03AB15, naloxone, Potassium citrate may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.]
[N07BB04, naltrexone, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Naltrexone.]
[N06BA01, amphetamine, The excretion of Amphetamine can be decreased when combined with Potassium citrate.]
[M02AA12, naproxen, Potassium citrate may increase the hyperkalemic activities of Naproxen.]
[N06AX21, duloxetine, Potassium citrate may increase the excretion rate of Duloxetine which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BX01, tolcapone, Potassium citrate may increase the excretion rate of Tolcapone which could result in a lower serum level and potentially a reduction in efficacy.]
[N01AH06, remifentanil, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Remifentanil.]
[B01AC17, tirofiban, Potassium citrate may increase the excretion rate of Tirofiban which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AA19, ampicillin, Potassium citrate may increase the excretion rate of Ampicillin which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AX16, plerixafor, Potassium citrate may increase the excretion rate of Plerixafor which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX23, desvenlafaxine, Potassium citrate may increase the excretion rate of Desvenlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[C09CA07, telmisartan, Potassium citrate may increase the hyperkalemic activities of Telmisartan.]
[J05AB11, valacyclovir, Potassium citrate may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CE01, inamrinone, Potassium citrate may increase the excretion rate of Amrinone which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA04, nicardipine, Potassium citrate may increase the hyperkalemic activities of Nicardipine.]
[C08CA05, nifedipine, Potassium citrate may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA17, niflumic acid, Potassium citrate may increase the hyperkalemic activities of Niflumic acid.]
[C08CA06, nimodipine, Potassium citrate may increase the hyperkalemic activities of Nimodipine.]
[C08CA07, nisoldipine, Potassium citrate may increase the excretion rate of Nisoldipine which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA08, nitrendipine, Potassium citrate may increase the hyperkalemic activities of Nitrendipine.]
[R07AX01, nitric oxide, Potassium citrate may increase the excretion rate of Nitric Oxide which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XE01, nitrofurantoin, Potassium citrate may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF03, zaleplon, Potassium citrate may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BC05, pramipexole, Potassium citrate may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[C02DD01, nitroprusside, Potassium citrate may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA03, norepinephrine, The risk or severity of Cardiac Arrhythmia can be increased when Norepinephrine is combined with Potassium citrate.]
[G02CA02, nylidrin, Potassium citrate may increase the hyperkalemic activities of Nylidrin.]
[B01AB08, reviparin, Potassium citrate may increase the hyperkalemic activities of Reviparin.]
[N02AA02, opium, Potassium citrate may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[G04CA02, tamsulosin, Potassium citrate may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01CF04, oxacillin, Potassium citrate may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA04, oxazepam, Potassium citrate may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AA02, oxprenolol, Potassium citrate may increase the hyperkalemic activities of Oxprenolol.]
[N02AA05, oxycodone, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Oxycodone.]
[N02AA11, oxymorphone, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Oxymorphone.]
[S01BC02, oxyphenbutazone, Potassium citrate may increase the hyperkalemic activities of Oxyphenbutazone.]
[S01AA04, oxytetracycline, The therapeutic efficacy of Oxytetracycline can be decreased when used in combination with Potassium citrate.]
[B01AB09, danaparoid, Potassium citrate may increase the hyperkalemic activities of Danaparoid.]
[N02AX06, tapentadol, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Tapentadol.]
[J04AB30, capreomycin, Potassium citrate may increase the excretion rate of Capreomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BD11, fesoterodine, Potassium citrate may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AA23, penbutolol, Potassium citrate may increase the excretion rate of Penbutolol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AG03, penfluridol, Potassium citrate may increase the hyperkalemic activities of Penfluridol.]
[J01CE09, penicillin G procaine, Potassium citrate may increase the excretion rate of Procaine benzylpenicillin which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AD01, pentazocine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Pentazocine.]
[N05CA01, pentobarbital, Potassium citrate may increase the excretion rate of Pentobarbital which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XX08, pentostatin, Potassium citrate may increase the excretion rate of Pentostatin which could result in a lower serum level and potentially a reduction in efficacy.]
[C04AD03, pentoxifylline, Potassium citrate may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[C08EX02, perhexiline, Potassium citrate may increase the hyperkalemic activities of Perhexiline.]
[N02AD02, phenazocine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Phenazocine.]
[G04BX06, phenazopyridine, Potassium citrate may increase the excretion rate of Phenazopyridine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AF03, phenelzine, Potassium citrate may increase the excretion rate of Phenelzine which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AB01, oxyphenisatin, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Oxyphenisatin.]
[N01AH04, phenoperidine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Phenoperidine.]
[A08AA01, phentermine, The excretion of Phentermine can be decreased when combined with Potassium citrate.]
[V03AB36, phentolamine, Potassium citrate may increase the excretion rate of Phentolamine which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA01, phenylbutazone, Potassium citrate may increase the hyperkalemic activities of Phenylbutazone.]
[S01AE05, levofloxacin, Potassium citrate may increase the excretion rate of Levofloxacin which could result in a lower serum level and potentially a reduction in efficacy.]
[B02BA01, vitamin K1, Potassium citrate may increase the excretion rate of Phylloquinone which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AB12, cidofovir, Potassium citrate may increase the excretion rate of Cidofovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CX01, mibefradil, Potassium citrate may increase the hyperkalemic activities of Mibefradil.]
[C07AA03, pindolol, Potassium citrate may increase the excretion rate of Pindolol which could result in a lower serum level and potentially a reduction in efficacy.]
[J01CA12, piperacillin, Potassium citrate may increase the excretion rate of Piperacillin which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BX03, piracetam, Potassium citrate may increase the excretion rate of Piracetam which could result in a lower serum level and potentially a reduction in efficacy.]
[C09CA02, eprosartan, Potassium citrate may increase the hyperkalemic activities of Eprosartan.]
[N02AC03, pirinitramide, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Piritramide.]
[S01BC06, piroxicam, Potassium citrate may increase the excretion rate of Piroxicam which could result in a lower serum level and potentially a reduction in efficacy.]
[C09CA04, irbesartan, Potassium citrate may increase the hyperkalemic activities of Irbesartan.]
[A10BG02, rosiglitazone, Potassium citrate may increase the excretion rate of Rosiglitazone which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AD15, polyethylene glycols, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Polyethylene glycol.]
[A10BH03, saxagliptin, Potassium citrate may increase the excretion rate of Saxagliptin which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA01, potassium chloride, Potassium citrate may increase the excretion rate of Potassium chloride which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AD04, insulin lispro, The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Potassium citrate.]
[C07AB01, practolol, Potassium citrate may increase the hyperkalemic activities of Practolol.]
[H02AB07, prednisone, Potassium citrate may increase the excretion rate of Prednisone which could result in a lower serum level and potentially a reduction in efficacy.]
[C01DX02, prenylamine, Potassium citrate may increase the hyperkalemic activities of Prenylamine.]
[M04AB01, probenecid, Potassium citrate may increase the excretion rate of Probenecid which could result in a lower serum level and potentially a reduction in efficacy.]
[C01BA02, procainamide, Potassium citrate may increase the excretion rate of Procainamide which could result in a lower serum level and potentially a reduction in efficacy.]
[C10AB05, fenofibrate, Potassium citrate may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AD02, promethazine, Potassium citrate may increase the excretion rate of Promethazine which could result in a lower serum level and potentially a reduction in efficacy.]
[C01BC03, propafenone, Potassium citrate may increase the hyperkalemic activities of Propafenone.]
[A03AB05, propantheline, Potassium citrate may increase the excretion rate of Propantheline which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AC04, propoxyphene, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Dextropropoxyphene.]
[C07AA05, propranolol, Potassium citrate may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CC04, rizatriptan, Potassium citrate may increase the excretion rate of Rizatriptan which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AC09, epoprostenol, Potassium citrate may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy.]
[R01BA02, pseudoephedrine, The excretion of Pseudoephedrine can be decreased when combined with Potassium citrate.]
[N07XX07, dalfampridine, Potassium citrate may increase the excretion rate of Dalfampridine which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CC01, pyrantel, Potassium citrate may increase the excretion rate of Pyrantel which could result in a lower serum level and potentially a reduction in efficacy.]
[J04AK01, pyrazinamide, Potassium citrate may increase the excretion rate of Pyrazinamide which could result in a lower serum level and potentially a reduction in efficacy.]
[A12BA05, potassium gluconate, Potassium gluconate may increase the hyperkalemic activities of Potassium citrate.]
[C01BA01, quinidine, Potassium citrate may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BA02, ranitidine, Potassium citrate may increase the excretion rate of Ranitidine which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AA01, rescinnamine, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Rescinnamine.]
[C02AA02, reserpine, Potassium citrate may increase the excretion rate of Reserpine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AP01, ribavirin, Potassium citrate may increase the excretion rate of Ribavirin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01AA09, rolitetracycline, The therapeutic efficacy of Rolitetracycline can be decreased when used in combination with Potassium citrate.]
[N02BA05, salicylamide, Potassium citrate may increase the hyperkalemic activities of Salicylamide.]
[A07EC01, sulfasalazine, Potassium citrate may increase the hyperkalemic activities of Sulfasalazine.]
[S01BC08, salicylic acid, Potassium citrate may increase the hyperkalemic activities of Salicylic acid.]
[N05CA06, secobarbital, Potassium citrate may increase the excretion rate of Secobarbital which could result in a lower serum level and potentially a reduction in efficacy.]
[A12CD01, sodium fluoride, Potassium citrate may increase the excretion rate of Sodium fluoride which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CC01, sorbitol, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Sorbitol.]
[C07AA07, sotalol, Potassium citrate may increase the hyperkalemic activities of Sotalol.]
[C03DA01, spironolactone, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Spironolactone.]
[S02DA03, antipyrine, Potassium citrate may increase the hyperkalemic activities of Antipyrine.]
[J01GA01, streptomycin, Potassium citrate may increase the excretion rate of Streptomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[M03AB01, succinylcholine, Potassium citrate may increase the hyperkalemic activities of Succinylcholine.]
[A02BX02, sucralfate, Potassium citrate may increase the excretion rate of Sucralfate which could result in a lower serum level and potentially a reduction in efficacy.]
[J01CG01, sulbactam, Potassium citrate may increase the excretion rate of Sulbactam which could result in a lower serum level and potentially a reduction in efficacy.]
[J01EC02, sulfadiazine, Potassium citrate may increase the excretion rate of Sulfadiazine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01EC01, sulfamethoxazole, Potassium citrate may increase the excretion rate of Sulfamethoxazole which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AB02, sulindac, Potassium citrate may increase the hyperkalemic activities of Sulindac.]
[M01AX04, apazone, Potassium citrate may increase the hyperkalemic activities of Azapropazone.]
[N05CD07, temazepam, Potassium citrate may increase the excretion rate of Temazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[R03CC03, terbutaline, Potassium citrate may increase the excretion rate of Terbutaline which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AE07, dabigatran etexilate, Potassium citrate may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.]
[G03BA03, testosterone, Potassium citrate may increase the excretion rate of Testosterone which could result in a lower serum level and potentially a reduction in efficacy.]
[S03AA02, tetracycline, Potassium citrate may increase the excretion rate of Tetracycline which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Potassium citrate may increase the excretion rate of Thiabendazole which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AD03, thiethylperazine, Potassium citrate may increase the excretion rate of Thiethylperazine which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE06, moxisylyte, Potassium citrate may increase the excretion rate of Moxisylyte which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AL03, tiapride, Potassium citrate may increase the excretion rate of Tiapride which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AC05, ticlopidine, Potassium citrate may increase the excretion rate of Ticlopidine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AX01, tilidine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Tilidine.]
[S01ED01, timolol, Potassium citrate may increase the excretion rate of Timolol which could result in a lower serum level and potentially a reduction in efficacy.]
[P01AB02, tinidazole, Potassium citrate may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AA12, tobramycin, Potassium citrate may increase the excretion rate of Tobramycin which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BB05, tolazamide, Potassium citrate may increase the excretion rate of Tolazamide which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CA01, tolbutamide, Potassium citrate may increase the excretion rate of Tolbutamide which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA21, tolmetin, Potassium citrate may increase the hyperkalemic activities of Tolmetin.]
[N02AX02, tramadol, Potassium citrate may increase the excretion rate of Tramadol which could result in a lower serum level and potentially a reduction in efficacy.]
[C03DB02, triamterene, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Triamterene.]
[N05CD05, triazolam, Potassium citrate may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Potassium citrate may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AD02, trifluridine, Potassium citrate may increase the excretion rate of Trifluridine which could result in a lower serum level and potentially a reduction in efficacy.]
[A03AA05, trimebutine, Potassium citrate may increase the excretion rate of Trimebutine which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AC02, trimethadione, Potassium citrate may increase the hyperkalemic activities of Trimethadione.]
[J01EA01, trimethoprim, Potassium citrate may increase the excretion rate of Trimethoprim which could result in a lower serum level and potentially a reduction in efficacy.]
[C09CA09, azilsartan medoxomil, Potassium citrate may increase the hyperkalemic activities of Azilsartan medoxomil.]
[R03DX07, roflumilast, Potassium citrate may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy.]
[L01FX04, ipilimumab, Potassium citrate may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.]
[R02AA14, oxyquinoline, Potassium citrate may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AA28, vancomycin, Potassium citrate may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AX21, ezogabine, Potassium citrate may increase the excretion rate of Ezogabine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AF01, rivaroxaban, Potassium citrate may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[C08DA01, verapamil, Potassium citrate may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX09, viloxazine, Potassium citrate may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AA03, warfarin, Potassium citrate may increase the excretion rate of Warfarin which could result in a lower serum level and potentially a reduction in efficacy.]
[M05BA05, tiludronic acid, Potassium citrate may increase the excretion rate of Tiludronic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[B06AC02, icatibant, Potassium citrate may increase the excretion rate of Icatibant which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC04, rabeprazole, Potassium citrate may increase the excretion rate of Rabeprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[G03AC10, drospirenone, Potassium citrate may increase the hyperkalemic activities of Drospirenone.]
[V03AC02, deferiprone, Potassium citrate may increase the excretion rate of Deferiprone which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Potassium citrate which could result in a higher serum level.]
[L01EJ01, ruxolitinib, Potassium citrate may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BD07, tolterodine, Potassium citrate may increase the excretion rate of Tolterodine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DH04, doripenem, Potassium citrate may increase the excretion rate of Doripenem which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB03, atenolol, Potassium citrate may increase the hyperkalemic activities of Atenolol.]
[M01CB03, auranofin, Potassium citrate may increase the excretion rate of Auranofin which could result in a lower serum level and potentially a reduction in efficacy.]
[B03XA04, peginesatide, Potassium citrate may increase the excretion rate of Peginesatide which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC07, azacitidine, Potassium citrate may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX01, azathioprine, Potassium citrate may increase the excretion rate of Azathioprine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC05, gemcitabine, Potassium citrate may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DF01, aztreonam, Potassium citrate may increase the excretion rate of Aztreonam which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BX01, baclofen, Potassium citrate may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA11, lorcaserin, Potassium citrate may increase the excretion rate of Lorcaserin which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BD12, mirabegron, Potassium citrate may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy.]
[L02BB04, enzalutamide, Potassium citrate may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AX04, linaclotide, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Linaclotide.]
[D02BA02, octinoxate, Potassium citrate may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BD02, rasagiline, Potassium citrate may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA13, lercanidipine, Potassium citrate may increase the hyperkalemic activities of Lercanidipine.]
[V09IX04, fluorodeoxyglucose F18, Potassium citrate may increase the excretion rate of Fludeoxyglucose (18F) which could result in a lower serum level and potentially a reduction in efficacy.]
[V08CA11, gadofosveset, Potassium citrate may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX08, teduglutide, Potassium citrate may increase the excretion rate of Teduglutide which could result in a lower serum level and potentially a reduction in efficacy.]
[C04AX11, bencyclane, Potassium citrate may increase the hyperkalemic activities of Bencyclane.]
[A10BH04, alogliptin, Potassium citrate may increase the excretion rate of Alogliptin which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX09, glycerol phenylbutyrate, Potassium citrate may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, Potassium citrate may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BA10, benorilate, Potassium citrate may increase the hyperkalemic activities of Benorilate.]
[A10BK02, canagliflozin, Potassium citrate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AX06, tegaserod, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Tegaserod.]
[A10AE05, insulin detemir, The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Potassium citrate.]
[L03AA12, ancestim, Potassium citrate may increase the excretion rate of Ancestim which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AH01, celecoxib, Potassium citrate may increase the hyperkalemic activities of Celecoxib.]
[N04AC01, benztropine, Potassium citrate may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.]
[R02AX03, benzydamine, Potassium citrate may increase the excretion rate of Benzydamine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01EE01, trametinib, Potassium citrate may increase the excretion rate of Trametinib which could result in a lower serum level and potentially a reduction in efficacy.]
[V09AX05, florbetapir F-18, Potassium citrate may increase the excretion rate of Florbetapir (18F) which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX28, levomilnacipran, Potassium citrate may increase the excretion rate of Levomilnacipran which could result in a lower serum level and potentially a reduction in efficacy.]
[C08EA02, bepridil, Potassium citrate may increase the hyperkalemic activities of Bepridil.]
[A10BJ03, lixisenatide, Potassium citrate may increase the excretion rate of Lixisenatide which could result in a lower serum level and potentially a reduction in efficacy.]
[C02KX04, macitentan, Potassium citrate may increase the excretion rate of Macitentan which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX26, vortioxetine, Potassium citrate may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.]
[G03AC08, etonogestrel, Potassium citrate may increase the excretion rate of Etonogestrel which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AP08, sofosbuvir, Potassium citrate may increase the excretion rate of Sofosbuvir which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Potassium citrate may increase the excretion rate of Droxidopa which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB04, acebutolol, Potassium citrate may increase the hyperkalemic activities of Acebutolol.]
[N05CH03, tasimelteon, Potassium citrate may increase the excretion rate of Tasimelteon which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA32, apremilast, Potassium citrate may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy.]
[L02BG02, formestane, Potassium citrate may increase the excretion rate of Formestane which could result in a lower serum level and potentially a reduction in efficacy.]
[S01ED02, betaxolol, Potassium citrate may increase the hyperkalemic activities of Betaxolol.]
[V03AB34, fomepizole, Potassium citrate may increase the excretion rate of Fomepizole which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BK03, empagliflozin, Empagliflozin may increase the diuretic activities of Potassium citrate.]
[V08AA01, diatrizoic acid, Potassium citrate may increase the excretion rate of Diatrizoate which could result in a lower serum level and potentially a reduction in efficacy.]
[V08AA04, iothalamic acid, Potassium citrate may increase the excretion rate of Diatrizoate which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AB04, phenolphthalein, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Phenolphthalein.]
[A06AH03, naloxegol, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Naloxegol.]
[A06AG02, bisacodyl, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Bisacodyl.]
[B01AF03, edoxaban, Potassium citrate may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BE01, acetaminophen, Potassium citrate may increase the excretion rate of Acetaminophen which could result in a lower serum level and potentially a reduction in efficacy.]
[L01DC01, bleomycin, Potassium citrate may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[A07DA06, eluxadoline, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Eluxadoline.]
[A06AD03, magnesium peroxide, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Magnesium peroxide.]
[M02AA25, aceclofenac, Potassium citrate may increase the excretion rate of Aceclofenac which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AB11, acemetacin, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Acemetacin.]
[A10AE06, insulin degludec, The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Potassium citrate.]
[V03AB37, idarucizumab, Potassium citrate may increase the excretion rate of Idarucizumab which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG03, ixazomib, Potassium citrate may increase the excretion rate of Ixazomib which could result in a lower serum level and potentially a reduction in efficacy.]
[M04AB05, lesinurad, Potassium citrate may increase the excretion rate of Lesinurad which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AE16, alminoprofen, Potassium citrate may increase the hyperkalemic activities of Alminoprofen.]
[N03AX23, brivaracetam, Potassium citrate may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA08, bromazepam, Potassium citrate may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[A02AD05, aluminum magnesium silicate, Potassium citrate may increase the excretion rate of Almasilate which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA01, amlodipine, Potassium citrate may increase the hyperkalemic activities of Amlodipine.]
[C03CA02, bumetanide, Potassium citrate may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, Potassium citrate may increase the excretion rate of Levobupivacaine which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AA19, bupranolol, Potassium citrate may increase the hyperkalemic activities of Bupranolol.]
[N07BC01, buprenorphine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Buprenorphine.]
[N05BE01, buspirone, Potassium citrate may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XX27, arsenic trioxide, Potassium citrate may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA03, clofezone, Potassium citrate may increase the excretion rate of Rabeprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AF01, butorphanol, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Butorphanol.]
[A06AX07, plecanatide, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Plecanatide.]
[A07EC04, balsalazide, Potassium citrate may increase the hyperkalemic activities of Balsalazide.]
[A06AH05, naldemedine, Potassium citrate may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy.]
[N07XX16, deutetrabenazine, Potassium citrate may increase the excretion rate of Deutetrabenazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BF02, pregabalin, Potassium citrate may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA07, benazepril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Benazepril.]
[P01CA02, benznidazole, Potassium citrate may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF06, abacavir, Potassium citrate may increase the excretion rate of Abacavir which could result in a lower serum level and potentially a reduction in efficacy.]
[N07XX13, valbenazine, Potassium citrate may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01MA23, delafloxacin, Potassium citrate may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC06, capecitabine, Potassium citrate may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB07, bisoprolol, Potassium citrate may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AA17, bopindolol, Potassium citrate may increase the hyperkalemic activities of Bopindolol.]
[C03DA03, canrenone, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Canrenone.]
[R03BA02, budesonide, Potassium citrate may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AB07, bumadizone, Potassium citrate may increase the hyperkalemic activities of Bumadizone.]
[R06AX18, acrivastine, Potassium citrate may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA01, captopril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Captopril.]
[L02BB05, apalutamide, Potassium citrate may increase the excretion rate of Apalutamide which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AF01, carbamazepine, Potassium citrate may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AC08, calcium polycarbophil, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Calcium polycarbophil.]
[C07AG02, carvedilol, Potassium citrate may increase the hyperkalemic activities of Carvedilol.]
[L04AA37, baricitinib, Potassium citrate may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD14, ceftibuten, Potassium citrate may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.]
[J01GB14, plazomicin, Potassium citrate may increase the excretion rate of Plazomicin which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB08, celiprolol, Potassium citrate may increase the hyperkalemic activities of Celiprolol.]
[A16AX14, migalastat, Potassium citrate may increase the excretion rate of Migalastat which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AX17, stiripentol, Potassium citrate may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[J01AA13, eravacycline, The therapeutic efficacy of Eravacycline can be decreased when used in combination with Potassium citrate.]
[J01AA14, sarecycline, The therapeutic efficacy of Sarecycline can be decreased when used in combination with Potassium citrate.]
[J01AA15, omadacycline, The therapeutic efficacy of Omadacycline can be decreased when used in combination with Potassium citrate.]
[S01GX12, cetirizine, Potassium citrate may increase the excretion rate of Cetirizine which could result in a lower serum level and potentially a reduction in efficacy.]
[D08AE05, chloroxylenol, Potassium citrate may increase the excretion rate of Chloroxylenol which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AC05, lornoxicam, Potassium citrate may increase the hyperkalemic activities of Lornoxicam.]
[L01AD01, carmustine, Potassium citrate may increase the excretion rate of Carmustine which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AX05, prucalopride, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Prucalopride.]
[C09AA08, cilazapril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Cilazapril.]
[B01AC23, cilostazol, Potassium citrate may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BA14, solriamfetol, Potassium citrate may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA09, clobazam, Potassium citrate may increase the excretion rate of Clobazam which could result in a lower serum level and potentially a reduction in efficacy.]
[J01AA11, clomocycline, The therapeutic efficacy of Clomocycline can be decreased when used in combination with Potassium citrate.]
[A06AB05, castor oil, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Castor oil.]
[C09CA06, candesartan, Potassium citrate may increase the hyperkalemic activities of Candesartan.]
[J01DC04, cefaclor, Potassium citrate may increase the excretion rate of Cefaclor which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DB05, cefadroxil, Potassium citrate may increase the excretion rate of Cefadroxil which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DC05, cefotetan, Potassium citrate may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD02, ceftazidime, Potassium citrate may increase the excretion rate of Ceftazidime which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD04, ceftriaxone, Potassium citrate may increase the excretion rate of Ceftriaxone which could result in a lower serum level and potentially a reduction in efficacy.]
[N07XX11, pitolisant, Potassium citrate may increase the excretion rate of Pitolisant which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE03, insulin, regular, pork, The therapeutic efficacy of Insulin pork can be decreased when used in combination with Potassium citrate.]
[A06AB03, danthron, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Dantron.]
[J01XX09, daptomycin, Potassium citrate may increase the excretion rate of Daptomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DB01, cephalexin, Potassium citrate may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DB09, cephradine, Potassium citrate may increase the excretion rate of Cefradine which could result in a lower serum level and potentially a reduction in efficacy.]
[M09AX08, golodirsen, Potassium citrate may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AX03, dezocine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Dezocine.]
[R02AA03, dichlorobenzyl alcohol, Potassium citrate may increase the excretion rate of Dichlorobenzyl alcohol which could result in a lower serum level and potentially a reduction in efficacy.]
[G03DB08, dienogest, Potassium citrate may increase the excretion rate of Dienogest which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AA08, dihydrocodeine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Dihydrocodeine.]
[M01AH02, rofecoxib, Potassium citrate may increase the hyperkalemic activities of Rofecoxib.]
[C08CA16, clevidipine, Potassium citrate may increase the excretion rate of Clevidipine which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AC04, droxicam, Potassium citrate may increase the hyperkalemic activities of Droxicam.]
[V08CA05, mangafodipir, Potassium citrate may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA27, dexketoprofen, Potassium citrate may increase the excretion rate of Dexketoprofen which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AX07, oliceridine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Oliceridine.]
[P01BA01, chloroquine, Potassium citrate may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AA01, chlorpromazine, Potassium citrate may increase the excretion rate of Chlorpromazine which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BB02, chlorpropamide, Potassium citrate may increase the excretion rate of Chlorpropamide which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Potassium citrate may increase the excretion rate of Chlorzoxazone which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BA07, ethenzamide, Potassium citrate may increase the hyperkalemic activities of Ethenzamide.]
[N02BA03, choline salicylate, Potassium citrate may increase the excretion rate of Choline salicylate which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BX18, vinpocetine, Potassium citrate may increase the hyperkalemic activities of Vinpocetine.]
[M01AB08, etodolac, Potassium citrate may increase the excretion rate of Etodolac which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA06, etofenamate, Potassium citrate may increase the hyperkalemic activities of Etofenamate.]
[M01AX25, chondroitin sulfates, Potassium citrate may increase the excretion rate of Chondroitin sulfate which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AE05, fenbufen, Potassium citrate may increase the hyperkalemic activities of Fenbufen.]
[C01CA19, fenoldopam, Potassium citrate may increase the excretion rate of Fenoldopam which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD15, cefdinir, Potassium citrate may increase the excretion rate of Cefdinir which could result in a lower serum level and potentially a reduction in efficacy.]
[S02BA08, fluocinolone acetonide, Potassium citrate may increase the excretion rate of Fluocinolone acetonide which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BG07, flupirtine, Potassium citrate may increase the excretion rate of Flupirtine which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AF01, insulin, regular, human, The therapeutic efficacy of Insulin human can be decreased when used in combination with Potassium citrate.]
[A02BA01, cimetidine, Potassium citrate may increase the excretion rate of Cimetidine which could result in a lower serum level and potentially a reduction in efficacy.]
[V08CA04, gadoteridol, Potassium citrate may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.]
[N07CA02, cinnarizine, Potassium citrate may increase the hyperkalemic activities of Cinnarizine.]
[S03AA07, ciprofloxacin, Potassium citrate may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XA01, cisplatin, Potassium citrate may increase the excretion rate of Cisplatin which could result in a lower serum level and potentially a reduction in efficacy.]
[C03DA05, finerenone, Potassium citrate may increase the hyperkalemic activities of Finerenone.]
[V09AB03, ioflupane I-123, Potassium citrate may increase the excretion rate of Ioflupane I-123 which could result in a lower serum level and potentially a reduction in efficacy.]
[V09AA01, technetium Tc 99m exametazime, Potassium citrate may increase the excretion rate of Technetium Tc-99m exametazime which could result in a lower serum level and potentially a reduction in efficacy.]
[V09AX06, florbetaben f-18, Potassium citrate may increase the excretion rate of Florbetaben (18F) which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB10, levobupivacaine, Potassium citrate may increase the excretion rate of Levobupivacaine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA04, clomipramine, Potassium citrate may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AE01, clonazepam, Potassium citrate may increase the excretion rate of Clonazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AH02, oseltamivir, Potassium citrate may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH02, clozapine, Potassium citrate may increase the excretion rate of Clozapine which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AX13, proquazone, Potassium citrate may increase the hyperkalemic activities of Proquazone.]
[R05DA04, codeine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Codeine.]
[M04AC01, colchicine, Potassium citrate may increase the excretion rate of Colchicine which could result in a lower serum level and potentially a reduction in efficacy.]
[A04AA03, tropisetron, Potassium citrate may increase the excretion rate of Tropisetron which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BX03, nateglinide, Potassium citrate may increase the excretion rate of Nateglinide which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BA16, imidazole-2-hydroxybenzoate, Potassium citrate may increase the hyperkalemic activities of Imidazole salicylate.]
[A10AE04, insulin glargine, The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Potassium citrate.]
[B01AC10, indobufen, Potassium citrate may increase the hyperkalemic activities of Indobufen.]
[J05AB14, valganciclovir, Potassium citrate may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C05BB03, invert sugar, Potassium citrate may increase the excretion rate of Invert sugar which could result in a lower serum level and potentially a reduction in efficacy.]
[V08AB09, iodixanol, Potassium citrate may increase the excretion rate of Iodixanol which could result in a lower serum level and potentially a reduction in efficacy.]
[V08AB05, iopromide, Potassium citrate may increase the excretion rate of Iopromide which could result in a lower serum level and potentially a reduction in efficacy.]
[V08AB07, ioversol, Potassium citrate may increase the excretion rate of Ioversol which could result in a lower serum level and potentially a reduction in efficacy.]
[V08AB12, ioxilan, Potassium citrate may increase the excretion rate of Ioxilan which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AH03, valdecoxib, Potassium citrate may increase the hyperkalemic activities of Valdecoxib.]
[N02CC05, almotriptan, Potassium citrate may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AH04, parecoxib, Potassium citrate may increase the hyperkalemic activities of Parecoxib.]
[J02AC02, itraconazole, Potassium citrate may increase the hyperkalemic activities of Itraconazole.]
[B01AB12, bemiparin, Potassium citrate may increase the hyperkalemic activities of Bemiparin.]
[S01AD03, acyclovir, Potassium citrate may increase the excretion rate of Acyclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA10, ketazolam, Potassium citrate may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AA06, kebuzone, Potassium citrate may increase the hyperkalemic activities of Kebuzone.]
[C08CA09, lacidipine, Potassium citrate may increase the hyperkalemic activities of Lacidipine.]
[A06AD12, lactitol, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Lactitol.]
[N03AX09, lamotrigine, Potassium citrate may increase the excretion rate of Lamotrigine which could result in a lower serum level and potentially a reduction in efficacy.]
[N07BC04, lofexidine, Potassium citrate may increase the excretion rate of Lofexidine which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AB09, lonazolac, Potassium citrate may increase the hyperkalemic activities of Lonazolac.]
[M02AA31, loxoprofen, Potassium citrate may increase the hyperkalemic activities of Loxoprofen.]
[C09AA03, lisinopril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Lisinopril.]
[A06AD01, magnesium carbonate, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Magnesium carbonate.]
[C08CA11, manidipine, Potassium citrate may increase the hyperkalemic activities of Manidipine.]
[C07AA14, mepindolol, Potassium citrate may increase the hyperkalemic activities of Mepindolol.]
[J01DH02, meropenem, Potassium citrate may increase the excretion rate of Meropenem which could result in a lower serum level and potentially a reduction in efficacy.]
[C04AX01, cyclandelate, Potassium citrate may increase the hyperkalemic activities of Cyclandelate.]
[R03CB02, methoxyphenamine, The excretion of Methoxyphenamine can be decreased when combined with Potassium citrate.]
[C03DA04, eplerenone, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Eplerenone.]
[N05AD03, metylperon, Potassium citrate may increase the excretion rate of Melperone which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, Potassium citrate may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[S01XA18, cyclosporine, Potassium citrate may increase the hyperkalemic activities of Cyclosporine.]
[C09AA13, moexipril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Moexipril.]
[M02AA02, mofebutazone, Potassium citrate may increase the hyperkalemic activities of Mofebutazone.]
[M01AX22, morniflumate, Potassium citrate may increase the hyperkalemic activities of Morniflumate.]
[M01AH05, etoricoxib, Potassium citrate may increase the hyperkalemic activities of Etoricoxib.]
[L01AX04, dacarbazine, Potassium citrate may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[M03CA01, dantrolene, Potassium citrate may increase the hyperkalemic activities of Dantrolene.]
[M01AX01, nabumetone, Potassium citrate may increase the hyperkalemic activities of Nabumetone.]
[N07BB05, nalmefene, Potassium citrate may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA15, potassium lactate, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Potassium lactate.]
[J01AA01, demeclocycline, The therapeutic efficacy of Demeclocycline can be decreased when used in combination with Potassium citrate.]
[C07AB12, nebivolol, Potassium citrate may increase the hyperkalemic activities of Nebivolol.]
[S01GX04, nedocromil, Potassium citrate may increase the excretion rate of Nedocromil which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX06, nefazodone, Potassium citrate may increase the excretion rate of Nefazodone which could result in a lower serum level and potentially a reduction in efficacy.]
[C01DX16, nicorandil, Potassium citrate may increase the excretion rate of Nicorandil which could result in a lower serum level and potentially a reduction in efficacy.]
[L02BB02, nilutamide, Potassium citrate may increase the excretion rate of Nilutamide which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA23, theodrenaline, The risk or severity of Cardiac Arrhythmia can be increased when Theodrenaline is combined with Potassium citrate.]
[R05DA06, normethadone, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Normethadone.]
[B01AX05, fondaparinux, Potassium citrate may increase the excretion rate of Fondaparinux which could result in a lower serum level and potentially a reduction in efficacy.]
[A07EC03, olsalazine, Potassium citrate may increase the hyperkalemic activities of Olsalazine.]
[N06AA01, desipramine, Potassium citrate may increase the excretion rate of Desipramine which could result in a lower serum level and potentially a reduction in efficacy.]
[H01BA02, desmopressin, Potassium citrate may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CH02, indigo carmine, Potassium citrate may increase the excretion rate of Indigotindisulfonic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DH03, ertapenem, Potassium citrate may increase the excretion rate of Ertapenem which could result in a lower serum level and potentially a reduction in efficacy.]
[C09XA02, aliskiren, Potassium citrate may increase the hyperkalemic activities of Aliskiren.]
[M01AE12, oxaprozin, Potassium citrate may increase the excretion rate of Oxaprozin which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BA02, dextroamphetamine, The excretion of Amphetamine can be decreased when combined with Potassium citrate.]
[N02AC01, dextromoramide, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Dextromoramide.]
[N07BC06, heroin, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Diamorphine.]
[P03AC04, permethrin, Potassium citrate may increase the excretion rate of Permethrin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA01, diazepam, Potassium citrate may increase the excretion rate of Diazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[R05DA08, pholcodine, Potassium citrate may increase the excretion rate of Pholcodine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Potassium citrate may increase the hyperkalemic activities of Diclofenac.]
[A03AA07, dicyclomine, Potassium citrate may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF02, didanosine, Potassium citrate may increase the excretion rate of Didanosine which could result in a lower serum level and potentially a reduction in efficacy.]
[A03AX04, pinaverium, Potassium citrate may increase the hyperkalemic activities of Pinaverium.]
[A08AA03, diethylpropion, The excretion of Diethylpropion can be decreased when combined with Potassium citrate.]
[C08CA03, isradipine, Potassium citrate may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy.]
[D07XC04, diflucortolone, Potassium citrate may increase the excretion rate of Difluocortolone which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BA11, diflunisal, Potassium citrate may increase the excretion rate of Diflunisal which could result in a lower serum level and potentially a reduction in efficacy.]
[C01AA05, digoxin, Potassium citrate may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AA03, hydromorphone, Potassium citrate may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX04, lenalidomide, Potassium citrate may increase the excretion rate of Lenalidomide which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BC01, potassium perchlorate, Potassium citrate may increase the excretion rate of Potassium perchlorate which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB04, pralidoxime, Potassium citrate may increase the excretion rate of Pralidoxime which could result in a lower serum level and potentially a reduction in efficacy.]
[C08DB01, diltiazem, Potassium citrate may increase the hyperkalemic activities of Diltiazem.]
[V03AB09, dimercaprol, Potassium citrate may increase the excretion rate of Dimercaprol which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AX03, dimethyl sulfoxide, Potassium citrate may increase the excretion rate of Dimethyl sulfoxide which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BB04, propyphenazone, Potassium citrate may increase the hyperkalemic activities of Propyphenazone.]
[M01AB14, proglumetacin, Potassium citrate may increase the hyperkalemic activities of Proglumetacin.]
[A07DA01, diphenoxylate, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Diphenoxylate.]
[C09AA06, quinapril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Quinapril.]
[C09AA05, ramipril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Ramipril.]
[S01AX06, resorcinol, Potassium citrate may increase the excretion rate of Resorcinol which could result in a lower serum level and potentially a reduction in efficacy.]
[C01BA03, disopyramide, Potassium citrate may increase the excretion rate of Disopyramide which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AE09, levocetirizine, Potassium citrate may increase the excretion rate of Levocetirizine which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB09, ropivacaine, Potassium citrate may increase the excretion rate of Ropivacaine which could result in a lower serum level and potentially a reduction in efficacy.]
[C03XA01, tolvaptan, Potassium citrate may increase the hyperkalemic activities of Tolvaptan.]
[G04BE08, tadalafil, Potassium citrate may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC05, ketorolac, Potassium citrate may increase the hyperkalemic activities of Ketorolac.]
[C01EB18, ranolazine, Potassium citrate may increase the excretion rate of Ranolazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BA06, salsalate, Potassium citrate may increase the hyperkalemic activities of Salsalate.]
[H05BA01, salmon calcitonin, Potassium citrate may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA07, dobutamine, Potassium citrate may increase the excretion rate of Dobutamine which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA04, dopamine, Potassium citrate may increase the excretion rate of Dopamine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA12, doxepin, Potassium citrate may increase the excretion rate of Doxepin which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AB06, sennosides, USP, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Sennosides.]
[J01AA02, doxycycline, Potassium citrate may increase the excretion rate of Doxycycline which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA10, sibutramine, Potassium citrate may increase the excretion rate of Sibutramine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AG05, sodium phosphate, Potassium citrate may increase the nephrotoxic activities of Sodium phosphate, monobasic.]
[A12CA02, sodium sulfate, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Sodium sulfate.]
[C09AA11, spirapril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Spirapril.]
[R03DA01, dyphylline, Potassium citrate may increase the excretion rate of Dyphylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CC01, sumatriptan, Potassium citrate may increase the excretion rate of Sumatriptan which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CX07, edrophonium, Potassium citrate may increase the excretion rate of Edrophonium which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB13, talinolol, Potassium citrate may increase the hyperkalemic activities of Talinolol.]
[L01AX03, temozolomide, Potassium citrate may increase the excretion rate of Temozolomide which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AC02, tenoxicam, Potassium citrate may increase the hyperkalemic activities of Tenoxicam.]
[G04BD05, terodiline, Potassium citrate may increase the hyperkalemic activities of Terodiline.]
[C07AA16, tertatolol, Potassium citrate may increase the hyperkalemic activities of Tertatolol.]
[C09AA02, enalapril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Enalapril.]
[M01AG02, tolfenamic acid, Potassium citrate may increase the hyperkalemic activities of Tolfenamic acid.]
[N06AG03, toloxatone, Potassium citrate may increase the excretion rate of Toloxatone which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BA09, atomoxetine, Potassium citrate may increase the excretion rate of Atomoxetine which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AX11, topiramate, Potassium citrate may increase the excretion rate of Topiramate which could result in a lower serum level and potentially a reduction in efficacy.]
[J01AA12, tigecycline, The therapeutic efficacy of Tigecycline can be decreased when used in combination with Potassium citrate.]
[C09AA10, trandolapril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Trandolapril.]
[N05CC01, chloral hydrate, Potassium citrate may increase the excretion rate of Chloral hydrate which could result in a lower serum level and potentially a reduction in efficacy.]
[S01FB02, ephedrine, The risk or severity of Cardiac Arrhythmia can be increased when Ephedrine is combined with Potassium citrate.]
[N06AX16, venlafaxine, Potassium citrate may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA12, mepirodipine, Potassium citrate may increase the hyperkalemic activities of Barnidipine.]
[S01EA01, epinephrine, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Potassium citrate.]
[C09AA15, zofenopril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Zofenopril.]
[M01AB04, zomepirac, Potassium citrate may increase the hyperkalemic activities of Zomepirac.]
[N03AX15, zonisamide, Potassium citrate may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AB06, insulin glulisine, human, The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Potassium citrate.]
[L01XA02, carboplatin, Potassium citrate may increase the excretion rate of Carboplatin which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AC02, guanfacine, Potassium citrate may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AX05, pidotimod, Potassium citrate may increase the excretion rate of Pidotimod which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD04, estazolam, Potassium citrate may increase the excretion rate of Estazolam which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC02, pantoprazole, Potassium citrate may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA03, estradiol, Potassium citrate may increase the excretion rate of Estradiol which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Potassium citrate may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[J04AK02, ethambutol, Potassium citrate may increase the excretion rate of Ethambutol which could result in a lower serum level and potentially a reduction in efficacy.]
[V08CA03, gadodiamide, Potassium citrate may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA15, gepefrine, The excretion of Gepefrine can be decreased when combined with Potassium citrate.]
[C01BD05, ibutilide, Potassium citrate may increase the excretion rate of Ibutilide which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AD01, ethosuximide, Potassium citrate may increase the hyperkalemic activities of Ethosuximide.]
[M01AC06, meloxicam, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Meloxicam.]
[S01XA06, ethylmorphine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Ethylmorphine.]
[N01AX07, etomidate, Potassium citrate may increase the excretion rate of Etomidate which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AD02, tacrolimus, Potassium citrate may increase the hyperkalemic activities of Tacrolimus.]
[P01AX07, trimetrexate, Potassium citrate may increase the excretion rate of Trimetrexate which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX12, bupropion, Potassium citrate may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AB08, fluvoxamine, Potassium citrate may increase the excretion rate of Fluvoxamine which could result in a lower serum level and potentially a reduction in efficacy.]
[L02AE02, leuprolide, Potassium citrate may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.]
[M01CB01, gold sodium thiomalate, Potassium citrate may increase the excretion rate of Sodium aurothiomalate which could result in a lower serum level and potentially a reduction in efficacy.]
[B05AA05, dextran, Potassium citrate may increase the excretion rate of Dextran which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AF02, dexrazoxane, Potassium citrate may increase the excretion rate of Dexrazoxane which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AA01, levocarnitine, Potassium citrate may increase the excretion rate of Levocarnitine which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA02, felodipine, Potassium citrate may increase the hyperkalemic activities of Felodipine.]
[C08EA01, fendiline, Potassium citrate may increase the hyperkalemic activities of Fendiline.]
[M01AE04, fenoprofen, Potassium citrate may increase the hyperkalemic activities of Fenoprofen.]
[N02AB03, fentanyl, Potassium citrate may increase the excretion rate of Fentanyl which could result in a lower serum level and potentially a reduction in efficacy.]
[R03CC02, albuterol, Potassium citrate may increase the excretion rate of Salbutamol which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BB06, clofarabine, Potassium citrate may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[N07AX03, cevimeline, Potassium citrate may increase the excretion rate of Cevimeline which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BD02, flavoxate, Potassium citrate may increase the excretion rate of Flavoxate which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BG04, floctafenine, Potassium citrate may increase the hyperkalemic activities of Floctafenine.]
[J02AC01, fluconazole, Potassium citrate may increase the excretion rate of Fluconazole which could result in a lower serum level and potentially a reduction in efficacy.]
[J02AX01, flucytosine, Potassium citrate may increase the excretion rate of Flucytosine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB25, flumazenil, Potassium citrate may increase the excretion rate of Flumazenil which could result in a lower serum level and potentially a reduction in efficacy.]
[N07CA03, flunarizine, Potassium citrate may increase the hyperkalemic activities of Flunarizine.]
[L01BC09, floxuridine, Potassium citrate may increase the excretion rate of Floxuridine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD01, flurazepam, Potassium citrate may increase the excretion rate of Flurazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC04, flurbiprofen, Potassium citrate may increase the excretion rate of Flurbiprofen which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AG01, fluspirilene, Potassium citrate may increase the hyperkalemic activities of Fluspirilene.]
[L02BB01, flutamide, Potassium citrate may increase the excretion rate of Flutamide which could result in a lower serum level and potentially a reduction in efficacy.]
[S02AA17, fosfomycin, Potassium citrate may increase the excretion rate of Fosfomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC03, tegafur, Potassium citrate may increase the excretion rate of Tegafur which could result in a lower serum level and potentially a reduction in efficacy.]
[C03CA01, furosemide, Potassium citrate may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, Potassium citrate may increase the excretion rate of Eszopiclone which could result in a lower serum level and potentially a reduction in efficacy.]
[C08DA02, gallopamil, Potassium citrate may increase the hyperkalemic activities of Gallopamil.]
[S01AD09, ganciclovir, Potassium citrate may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C10AB04, gemfibrozil, Potassium citrate may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XA03, telavancin, Potassium citrate may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AD03, methsuximide, Potassium citrate may increase the hyperkalemic activities of Methsuximide.]
[N01AH02, alfentanil, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Alfentanil.]
[A10BB07, glipizide, Potassium citrate may increase the excretion rate of Glipizide which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CM18, dexmedetomidine, Potassium citrate may increase the excretion rate of Dexmedetomidine which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AX01, glycerin, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Glycerin.]
[L01EX02, sorafenib, Potassium citrate may increase the excretion rate of Sorafenib which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB09, esmolol, Potassium citrate may increase the hyperkalemic activities of Esmolol.]
[M01CB04, aurothioglucose, Potassium citrate may increase the excretion rate of Aurothioglucose which could result in a lower serum level and potentially a reduction in efficacy.]
[S01LA03, pegaptanib, Potassium citrate may increase the excretion rate of Pegaptanib which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA09, fosinopril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Fosinopril.]
[S01EX01, guanethidine, Potassium citrate may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.]
[L02AE03, goserelin, Potassium citrate may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD01, haloperidol, Potassium citrate may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH04, quetiapine, Potassium citrate may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BX13, idebenone, Potassium citrate may increase the excretion rate of Idebenone which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AD05, insulin aspart, human, The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Potassium citrate.]
[M04AA01, allopurinol, Potassium citrate may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[C09CA01, losartan, Potassium citrate may increase the hyperkalemic activities of Losartan.]
[S01XA14, heparin, Potassium citrate may increase the hyperkalemic activities of Heparin.]
[G03DC01, allylestrenol, Potassium citrate may increase the excretion rate of Allylestrenol which could result in a lower serum level and potentially a reduction in efficacy.]
[A07EC02, mesalamine, Potassium citrate may increase the hyperkalemic activities of Mesalazine.]
[C01CE02, milrinone, Potassium citrate may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA10, nilvadipine, Potassium citrate may increase the hyperkalemic activities of Nilvadipine.]
[M02AA26, nimesulide, Potassium citrate may increase the hyperkalemic activities of Nimesulide.]
[C09AA04, perindopril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Perindopril.]
[C02DB02, hydralazine, Potassium citrate may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[R05DA03, hydrocodone, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Hydrocodone.]
[B05XA17, potassium acetate, Potassium citrate may increase the excretion rate of Potassium acetate which could result in a lower serum level and potentially a reduction in efficacy.]
[S01XA07, aluminum potassium sulfate, Potassium alum may increase the hyperkalemic activities of Potassium citrate.]
[M01AG01, mefenamic acid, Potassium citrate may increase the hyperkalemic activities of Mefenamic acid.]
[C01DA05, pentaerythritol tetranitrate, Potassium citrate may increase the excretion rate of Pentaerythritol tetranitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[A12CD02, sodium monofluorophosphate, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Sodium fluorophosphate.]
[V03AB33, hydroxocobalamin, Potassium citrate may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BD06, propiverine, Potassium citrate may increase the excretion rate of Propiverine which could result in a lower serum level and potentially a reduction in efficacy.]
[B05AA07, hetastarch, Potassium citrate may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.]
[R02AX02, ibuprofen, Potassium citrate may increase the excretion rate of Ibuprofen which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA08, sodium acetate, Potassium citrate may increase the excretion rate of Sodium acetate which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AD21, sodium tartrate, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Sodium tartrate.]
[L01AA06, ifosfamide, Potassium citrate may increase the excretion rate of Ifosfamide which could result in a lower serum level and potentially a reduction in efficacy.]
[N01AH03, sufentanil, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Sufentanil.]
[N06AA02, imipramine, Potassium citrate may increase the excretion rate of Imipramine which could result in a lower serum level and potentially a reduction in efficacy.]
[R01AD07, tixocortol, Potassium citrate may increase the excretion rate of Tixocortol which could result in a lower serum level and potentially a reduction in efficacy.]
[L01CE01, topotecan, Potassium citrate may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.]
[C03BA11, indapamide, Potassium citrate may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Potassium citrate may increase the hyperkalemic activities of Indomethacin.]
[N06AX17, milnacipran, Potassium citrate may increase the excretion rate of Milnacipran which could result in a lower serum level and potentially a reduction in efficacy.]
[S01XA28, varenicline, Potassium citrate may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BH01, sitagliptin, Potassium citrate may increase the excretion rate of Sitagliptin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA12, alprazolam, Potassium citrate may increase the excretion rate of Alprazolam which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CH02, ramelteon, Potassium citrate may increase the excretion rate of Ramelteon which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AA01, alprenolol, Potassium citrate may increase the hyperkalemic activities of Alprenolol.]
[V03AB01, ipecac, Potassium citrate may increase the excretion rate of Ipecac which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA16, imidapril, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Imidapril.]
[J04AC01, isoniazid, Potassium citrate may increase the excretion rate of Isoniazid which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AX05, inosine pranobex, Potassium citrate may increase the excretion rate of Inosine pranobex which could result in a lower serum level and potentially a reduction in efficacy.]
[D10BA01, isotretinoin, Potassium citrate may increase the excretion rate of Isotretinoin which could result in a lower serum level and potentially a reduction in efficacy.]
[A02AB01, aluminum hydroxide, Potassium citrate can cause an increase in the absorption of Aluminum hydroxide resulting in an increased serum concentration and potentially a worsening of adverse effects.]
[N01AX03, ketamine, Potassium citrate may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AC22, prasugrel, Potassium citrate may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.]
[J02AB02, ketoconazole, Potassium citrate may increase the hyperkalemic activities of Ketoconazole.]
[M02AA10, ketoprofen, Potassium citrate may increase the excretion rate of Ketoprofen which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AG01, labetalol, Potassium citrate may increase the excretion rate of Labetalol which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BB01, amantadine, Potassium citrate may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AD11, lactulose, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Lactulose.]
[A06AX03, lubiprostone, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Lubiprostone.]
[C08EX01, lidoflazine, Potassium citrate may increase the hyperkalemic activities of Lidoflazine.]
[C03DB01, amiloride, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Amiloride.]
[A07DA03, loperamide, Potassium citrate may increase the hyperkalemic activities of Loperamide.]
[N05BA06, lorazepam, Potassium citrate may increase the excretion rate of Lorazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[J01AA04, lymecycline, The therapeutic efficacy of Lymecycline can be decreased when used in combination with Potassium citrate.]
[B05XA11, magnesium chloride, Potassium citrate may increase the excretion rate of Magnesium chloride which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BX01, magnesium hydroxide, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Magnesium hydroxide.]
[V04CC02, magnesium sulfate, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Magnesium sulfate.]
[L01BA05, pralatrexate, Potassium citrate may increase the excretion rate of Pralatrexate which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CX04, mannitol, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Mannitol.]
[N06AA21, maprotiline, Potassium citrate may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy.]
[C02BB01, mecamylamine, Potassium citrate may increase the excretion rate of Mecamylamine which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA18, meclofenamic acid, Potassium citrate may increase the excretion rate of Meclofenamic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AB07, cascara sagrada, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Frangula purshiana bark.]
[B01AB06, nadroparin, Potassium citrate may increase the hyperkalemic activities of Nadroparin.]
[B01AB05, enoxaparin, Potassium citrate may increase the hyperkalemic activities of Enoxaparin.]
[B01AB04, dalteparin, Potassium citrate may increase the hyperkalemic activities of Dalteparin.]
[N06DX01, memantine, The excretion of Memantine can be decreased when combined with Potassium citrate.]
[N02AB02, meperidine, Potassium citrate may increase the excretion rate of Meperidine which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA11, mephentermine, The excretion of Mephentermine can be decreased when combined with Potassium citrate.]
[N01BB03, mepivacaine, Potassium citrate may increase the excretion rate of Mepivacaine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AX05, meptazinol, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Meptazinol.]
[G04BX16, tiopronin, Potassium citrate may increase the excretion rate of Tiopronin which could result in a lower serum level and potentially a reduction in efficacy.]
[C03BC01, mersalyl, Potassium citrate may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Potassium citrate may increase the excretion rate of Paliperidone which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BA02, metformin, Potassium citrate may increase the excretion rate of Metformin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01AA05, methacycline, The therapeutic efficacy of Metacycline can be decreased when used in combination with Potassium citrate.]
[N07BC02, methadone, Potassium citrate may increase the excretion rate of Methadone which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BA03, methamphetamine, The excretion of Metamfetamine can be decreased when combined with Potassium citrate.]
[J05AF05, lamivudine, Potassium citrate may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, Potassium citrate may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BA04, pemetrexed, Potassium citrate may increase the excretion rate of Pemetrexed which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BG08, ziconotide, The risk or severity of CNS depression can be increased when Potassium citrate is combined with Ziconotide.]
[L04AX03, methotrexate, Potassium citrate may increase the excretion rate of Methotrexate which could result in a lower serum level and potentially a reduction in efficacy.]
[D05BA02, methoxsalen, Potassium citrate may increase the excretion rate of Methoxsalen which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AC06, methylcellulose, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Methylcellulose.]
[C02AB01, methyldopa, Potassium citrate may increase the excretion rate of Methyldopa which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CG05, methylene blue, Potassium citrate may increase the excretion rate of Methylene blue which could result in a lower serum level and potentially a reduction in efficacy.]
[G03EK01, methyltestosterone, Potassium citrate may increase the excretion rate of Methyltestosterone which could result in a lower serum level and potentially a reduction in efficacy.]
[C03BA08, metolazone, Potassium citrate may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Potassium citrate may increase the excretion rate of Metoprolol which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CD01, metyrapone, Potassium citrate may increase the excretion rate of Metyrapone which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BB03, aminopyrine, Potassium citrate may increase the hyperkalemic activities of Aminophenazone.]
[B01AB07, parnaparin, Potassium citrate may increase the hyperkalemic activities of Parnaparin.]
[N05CD08, midazolam, Potassium citrate may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB10, tinzaparin, Potassium citrate may increase the hyperkalemic activities of Tinzaparin.]
[A06AA01, mineral oil, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Mineral oil.]
[J05AH01, zanamivir, Potassium citrate may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.]
[C09CA03, valsartan, Potassium citrate may increase the hyperkalemic activities of Valsartan.]
[J01AA08, minocycline, The therapeutic efficacy of Minocycline can be decreased when used in combination with Potassium citrate.]
[N06BA12, lisdexamfetamine, The excretion of Lisdexamfetamine can be decreased when combined with Potassium citrate.]
[L03AC01, aldesleukin, Potassium citrate may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.]
[C01BD01, amiodarone, Potassium citrate may increase the hyperkalemic activities of Amiodarone.]
[N06AA09, amitriptyline, Potassium citrate may increase the excretion rate of Amitriptyline which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AA01, morphine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Morphine.]
[A04AA05, palonosetron, Potassium citrate may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AB05, certolizumab pegol, Potassium citrate may increase the excretion rate of Certolizumab pegol which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BA01, ammonium chloride, Potassium citrate may increase the excretion rate of Ammonium chloride which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA06, mycophenolic acid, Potassium citrate may increase the excretion rate of Mycophenolic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AA12, nadolol, Potassium citrate may increase the excretion rate of Nadolol which could result in a lower serum level and potentially a reduction in efficacy.]
[J01CA04, amoxicillin, Potassium citrate may increase the excretion rate of Amoxicillin which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AF02, nalbuphine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Nalbuphine.]
[V03AB15, naloxone, Potassium citrate may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.]
[N07BB04, naltrexone, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Naltrexone.]
[N06BA01, amphetamine, The excretion of Amphetamine can be decreased when combined with Potassium citrate.]
[M02AA12, naproxen, Potassium citrate may increase the hyperkalemic activities of Naproxen.]
[N06AX21, duloxetine, Potassium citrate may increase the excretion rate of Duloxetine which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BX01, tolcapone, Potassium citrate may increase the excretion rate of Tolcapone which could result in a lower serum level and potentially a reduction in efficacy.]
[N01AH06, remifentanil, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Remifentanil.]
[B01AC17, tirofiban, Potassium citrate may increase the excretion rate of Tirofiban which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AA19, ampicillin, Potassium citrate may increase the excretion rate of Ampicillin which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AX16, plerixafor, Potassium citrate may increase the excretion rate of Plerixafor which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX23, desvenlafaxine, Potassium citrate may increase the excretion rate of Desvenlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[C09CA07, telmisartan, Potassium citrate may increase the hyperkalemic activities of Telmisartan.]
[J05AB11, valacyclovir, Potassium citrate may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CE01, inamrinone, Potassium citrate may increase the excretion rate of Amrinone which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA04, nicardipine, Potassium citrate may increase the hyperkalemic activities of Nicardipine.]
[C08CA05, nifedipine, Potassium citrate may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA17, niflumic acid, Potassium citrate may increase the hyperkalemic activities of Niflumic acid.]
[C08CA06, nimodipine, Potassium citrate may increase the hyperkalemic activities of Nimodipine.]
[C08CA07, nisoldipine, Potassium citrate may increase the excretion rate of Nisoldipine which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA08, nitrendipine, Potassium citrate may increase the hyperkalemic activities of Nitrendipine.]
[R07AX01, nitric oxide, Potassium citrate may increase the excretion rate of Nitric Oxide which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XE01, nitrofurantoin, Potassium citrate may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF03, zaleplon, Potassium citrate may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BC05, pramipexole, Potassium citrate may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[C02DD01, nitroprusside, Potassium citrate may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA03, norepinephrine, The risk or severity of Cardiac Arrhythmia can be increased when Norepinephrine is combined with Potassium citrate.]
[G02CA02, nylidrin, Potassium citrate may increase the hyperkalemic activities of Nylidrin.]
[B01AB08, reviparin, Potassium citrate may increase the hyperkalemic activities of Reviparin.]
[N02AA02, opium, Potassium citrate may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[G04CA02, tamsulosin, Potassium citrate may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01CF04, oxacillin, Potassium citrate may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA04, oxazepam, Potassium citrate may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AA02, oxprenolol, Potassium citrate may increase the hyperkalemic activities of Oxprenolol.]
[N02AA05, oxycodone, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Oxycodone.]
[N02AA11, oxymorphone, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Oxymorphone.]
[S01BC02, oxyphenbutazone, Potassium citrate may increase the hyperkalemic activities of Oxyphenbutazone.]
[S01AA04, oxytetracycline, The therapeutic efficacy of Oxytetracycline can be decreased when used in combination with Potassium citrate.]
[B01AB09, danaparoid, Potassium citrate may increase the hyperkalemic activities of Danaparoid.]
[N02AX06, tapentadol, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Tapentadol.]
[J04AB30, capreomycin, Potassium citrate may increase the excretion rate of Capreomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BD11, fesoterodine, Potassium citrate may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AA23, penbutolol, Potassium citrate may increase the excretion rate of Penbutolol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AG03, penfluridol, Potassium citrate may increase the hyperkalemic activities of Penfluridol.]
[J01CE09, penicillin G procaine, Potassium citrate may increase the excretion rate of Procaine benzylpenicillin which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AD01, pentazocine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Pentazocine.]
[N05CA01, pentobarbital, Potassium citrate may increase the excretion rate of Pentobarbital which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XX08, pentostatin, Potassium citrate may increase the excretion rate of Pentostatin which could result in a lower serum level and potentially a reduction in efficacy.]
[C04AD03, pentoxifylline, Potassium citrate may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[C08EX02, perhexiline, Potassium citrate may increase the hyperkalemic activities of Perhexiline.]
[N02AD02, phenazocine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Phenazocine.]
[G04BX06, phenazopyridine, Potassium citrate may increase the excretion rate of Phenazopyridine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AF03, phenelzine, Potassium citrate may increase the excretion rate of Phenelzine which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AB01, oxyphenisatin, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Oxyphenisatin.]
[N01AH04, phenoperidine, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Phenoperidine.]
[A08AA01, phentermine, The excretion of Phentermine can be decreased when combined with Potassium citrate.]
[V03AB36, phentolamine, Potassium citrate may increase the excretion rate of Phentolamine which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA01, phenylbutazone, Potassium citrate may increase the hyperkalemic activities of Phenylbutazone.]
[S01AE05, levofloxacin, Potassium citrate may increase the excretion rate of Levofloxacin which could result in a lower serum level and potentially a reduction in efficacy.]
[B02BA01, vitamin K1, Potassium citrate may increase the excretion rate of Phylloquinone which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AB12, cidofovir, Potassium citrate may increase the excretion rate of Cidofovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CX01, mibefradil, Potassium citrate may increase the hyperkalemic activities of Mibefradil.]
[C07AA03, pindolol, Potassium citrate may increase the excretion rate of Pindolol which could result in a lower serum level and potentially a reduction in efficacy.]
[J01CA12, piperacillin, Potassium citrate may increase the excretion rate of Piperacillin which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BX03, piracetam, Potassium citrate may increase the excretion rate of Piracetam which could result in a lower serum level and potentially a reduction in efficacy.]
[C09CA02, eprosartan, Potassium citrate may increase the hyperkalemic activities of Eprosartan.]
[N02AC03, pirinitramide, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Piritramide.]
[S01BC06, piroxicam, Potassium citrate may increase the excretion rate of Piroxicam which could result in a lower serum level and potentially a reduction in efficacy.]
[C09CA04, irbesartan, Potassium citrate may increase the hyperkalemic activities of Irbesartan.]
[A10BG02, rosiglitazone, Potassium citrate may increase the excretion rate of Rosiglitazone which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AD15, polyethylene glycols, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Polyethylene glycol.]
[A10BH03, saxagliptin, Potassium citrate may increase the excretion rate of Saxagliptin which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA01, potassium chloride, Potassium citrate may increase the excretion rate of Potassium chloride which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AD04, insulin lispro, The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Potassium citrate.]
[C07AB01, practolol, Potassium citrate may increase the hyperkalemic activities of Practolol.]
[H02AB07, prednisone, Potassium citrate may increase the excretion rate of Prednisone which could result in a lower serum level and potentially a reduction in efficacy.]
[C01DX02, prenylamine, Potassium citrate may increase the hyperkalemic activities of Prenylamine.]
[M04AB01, probenecid, Potassium citrate may increase the excretion rate of Probenecid which could result in a lower serum level and potentially a reduction in efficacy.]
[C01BA02, procainamide, Potassium citrate may increase the excretion rate of Procainamide which could result in a lower serum level and potentially a reduction in efficacy.]
[C10AB05, fenofibrate, Potassium citrate may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AD02, promethazine, Potassium citrate may increase the excretion rate of Promethazine which could result in a lower serum level and potentially a reduction in efficacy.]
[C01BC03, propafenone, Potassium citrate may increase the hyperkalemic activities of Propafenone.]
[A03AB05, propantheline, Potassium citrate may increase the excretion rate of Propantheline which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AC04, propoxyphene, The therapeutic efficacy of Potassium citrate can be decreased when used in combination with Dextropropoxyphene.]
[C07AA05, propranolol, Potassium citrate may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CC04, rizatriptan, Potassium citrate may increase the excretion rate of Rizatriptan which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AC09, epoprostenol, Potassium citrate may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy.]
[R01BA02, pseudoephedrine, The excretion of Pseudoephedrine can be decreased when combined with Potassium citrate.]
[N07XX07, dalfampridine, Potassium citrate may increase the excretion rate of Dalfampridine which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CC01, pyrantel, Potassium citrate may increase the excretion rate of Pyrantel which could result in a lower serum level and potentially a reduction in efficacy.]
[J04AK01, pyrazinamide, Potassium citrate may increase the excretion rate of Pyrazinamide which could result in a lower serum level and potentially a reduction in efficacy.]
[A12BA05, potassium gluconate, Potassium gluconate may increase the hyperkalemic activities of Potassium citrate.]
[C01BA01, quinidine, Potassium citrate may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BA02, ranitidine, Potassium citrate may increase the excretion rate of Ranitidine which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AA01, rescinnamine, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Rescinnamine.]
[C02AA02, reserpine, Potassium citrate may increase the excretion rate of Reserpine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AP01, ribavirin, Potassium citrate may increase the excretion rate of Ribavirin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01AA09, rolitetracycline, The therapeutic efficacy of Rolitetracycline can be decreased when used in combination with Potassium citrate.]
[N02BA05, salicylamide, Potassium citrate may increase the hyperkalemic activities of Salicylamide.]
[A07EC01, sulfasalazine, Potassium citrate may increase the hyperkalemic activities of Sulfasalazine.]
[S01BC08, salicylic acid, Potassium citrate may increase the hyperkalemic activities of Salicylic acid.]
[N05CA06, secobarbital, Potassium citrate may increase the excretion rate of Secobarbital which could result in a lower serum level and potentially a reduction in efficacy.]
[A12CD01, sodium fluoride, Potassium citrate may increase the excretion rate of Sodium fluoride which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CC01, sorbitol, The risk or severity of adverse effects can be increased when Potassium citrate is combined with Sorbitol.]
[C07AA07, sotalol, Potassium citrate may increase the hyperkalemic activities of Sotalol.]
[C03DA01, spironolactone, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Spironolactone.]
[C01DA14, isosorbide mononitrate, Potassium citrate may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[D10AX03, azelaic acid, Potassium citrate may increase the excretion rate of Azelaic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AE11, tiaprofenic acid, Potassium citrate may increase the hyperkalemic activities of Tiaprofenic acid.]
